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ABSTRACT
Background: Traumatic Brain Injury (TBI) is a leading cause of morbidity and mortality
among adults in the US (Ma, Chan, & Carruthers, 2014; Raj et al., 2015). According to
epidemiological estimates put forth by the CDC, of the 1.7 million TBIs that occur
annually in the United States, 80% are mild TBI (mTBI) (Ma, Chan, & Carruthers, 2014).
At the sub-acute stage, mTBI patients often report experiencing post-concussion
symptoms that include somatic (nausea, headache, dizziness), cognitive (poor attention,
memory, and executive function), and behavioral or emotional changes (irritability,
depression, emotional lability, anxiety) following their injury (Levin & Diza-Arrastia,
2015).
Study Aims: The specific aims of the current study were to: 1) investigate the
relationship between mood, subjective complaints of cognitive symptoms, and executive
functioning (EF) performance in mTBI and control participants at the sub-acute time
point; 2) evaluate the role of mood in understanding group differences in EF and
subjective cognitive symptom complaints; 3) examine changes in mood and subjective
cognitive symptom complaints in the mTBI group over time and determine if
demographic factors, specifically ethnicity, impact mood, EF, and their relationship.
iv

Participants and Methods: Participants were 52 individuals recruited from the
Departments of Neurosurgery and Emergency Medicine from UNMHSC within two
weeks following a mTBI. Control participants included 32 sex- and age- matched
individuals from the Albuquerque, New Mexico community. Participants attended two
assessment sessions; the first session was 3-14 days post injury and the second session
was ~2 months post injury. Participants completed self-report measures of postconcussion symptoms (the Neurobehavioral Symptom Inventory, the Frontal Systems
Behavior Scale, the Patient-Reported Measurement Information System, the Rivermead
Post-Concussion Symptoms Questionnaire) and a depression measure (BDI-II), as well as
an objective neuropsychological functioning measure (the Executive Abilities: Measure
and Instruments for Neurobehavioral Evaluation and Research assessment battery (NIHEXAMINER) and a measure of premorbid intelligence (the Test of Premorbid
Intelligence).
Results: mTBI patients reported experiencing significantly worse mood and more
subjective cognitive symptom complaints compared to healthy controls at two weeks post
injury. While mTBI participants and healthy controls differed in estimates of premorbid
intelligence, they did not differ in objectively measured EF. Across all self-report
measures individuals with a mTBI did not demonstrate improvements in mood or
symptoms between the first and second session. The current estimate of a small, nonsignificant effect size (d = .14) for group differences on the NIH-EXAMINER is
consistent with reports from previous studies. Effect sizes for mood (d = .90) and
subjective symptom reporting (d = .94) were much larger, and represent important targets
for clinical intervention.
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Conclusions: EF deficits were not present in the sub-acute time frame, but group
differences in depressive mood and the number of subjective complaints were prominent.
Depression appears to be a critical treatment target for improving quality of life in mTBI
patients, in contrast to EF functioning.
Keywords: Mild Traumatic Brain Injury, mTBI, Brain Injury, Executive Function,
Subjective Cognitive Complaints, NIH-EXAMINER
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INTRODUCTION
Traumatic Brain Injury (TBI) is a leading cause of morbidity and mortality in the
United States affecting about 1.74 million people each year (Ma, Chan, & Carruthers,
2014; Raj et al., 2015). The public health burden of TBI is far-reaching, with TBI
resulting in approximately 1.365 million emergency department visits, 275,000
hospitalizations, and 52,000 deaths yearly (Ma, Chan, & Carruthers, 2014). TBI is a
significant public health burden and long-term disability figures are staggering, with a
prevalence rate of 3.32 million individuals on long-term disability (Zaloshnja, Miller,
Langlois, & Selassie, 2008). Among traditionally underserved populations, the
prevalence and impact of a TBI is noteworthy. Blacks have the highest rate of TBI, with a
reported rate of 78.7 per 100,000 individuals, followed by Whites, then American Indians
and Alaskan Natives, Asians, or Pacific Islanders (Faul & Coronado, 2015). Furthermore,
the Hispanic population has a higher than average incidence of TBI when compared to
non-Hispanic White (NHW) individuals with reported rates of 262 per 100,000
individuals for Hispanics (Arango-Lasprilla et al., 2007). The estimated annual number of
sustained TBIs is 998,176 for males and 693,329 for females, meaning that males sustain
TBIs 1.4 times more often than their female counterparts (Faul, Xu, Wald, & Coronado,
2010).
The direct and indirect costs of TBIs affect multiple levels of the healthcare
system including the government, the taxpayer, and the survivor. Direct medical costs
alone have been estimated at $48.3 billion to $76.5 billion (Ma, Chan, & Carruthers,
2014). Indirect costs are appraised at $51.2 billion, due to missed work and lost
productivity (Rutland-Brown, Langlois, & Thomas, 2006). In addition to the significant
1

monetary cost, there are many other severe consequences facing the TBI survivor. These
often include difficulties with activities of daily living, financial independence, and social
reintegration (Ma, Chan, & Carruthers, 2014).
Diagnostic Criteria. TBI is defined by the Center for Disease Control (CDC) as
“an injury that disrupts the normal function of the brain. It can be caused by a bump,
blow, or jolt to the head or a penetrating head injury” (CDC, 2014, p.2). Various
approaches have been used to categorize TBIs based on severity, type of injury, and the
presence or absence of specific symptoms (Friedland, 2013). Injury severity is based on
the following criteria, loss of consciousness (LOC), post traumatic amnesia (PTA),
Glasgow Coma Scale rating (GCS), and presence or absence of neuroimaging findings.
LOC is defined as the presence or absence of LOC and the duration of time the individual
is unconscious. LOC can range from seconds to weeks and varying lengths of LOC result
in different determinations of TBI severity. PTA occurs during the period following a
brain injury, usually after LOC, wherein the individual is conscious but is experiencing
amnesia, meaning he/she is unable to maintain continuous memory. Of note, LOC does
not have to occur for PTA to be present. To further assess injury severity, medical
providers often administer the GCS in the acute setting following the injury (Friedland,
2013). The GCS assess coma and impaired level of consciousness and is considered the
gold standard in assessment after brain injury (Teasdale & Jennett, 1974). Verbal
performance, motor responsiveness and eye opening are independently measured to make
an overall GCS score. Finally, in the event of a more severe injury, medical providers
may preform neuroimaging studies to determine if brain abnormalities are present. The
four components LOC, PTA, GCS, and neuroimaging results taken together provide
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clinicians with an approximate measure of TBI severity categorized as: mild, moderate
and severe. Relying on one indicator of injury severity can be problematic because
medical interventions may complicate assessment. For example, facial injuries or
intubation can limit the accuracy of GCS rating scores.
A mild TBI (mTBI) is defined by the following criteria: LOC that lasts for 30
minutes or less, PTA lasting for less than 24 hours, a GCS score between 13-15 and
negative neuroimaging findings. A moderate TBI is defined by the following criteria:
LOC that lasts for 1-24 hours, PTA lasting for 1-7 days, a GCS score between 9-12, and
in some cases, abnormal brain imaging results. Severe TBI is defined by the following
criteria: LOC that lasts for more than 24 hours, PTA lasting for more than 7 days, a GCS
score between 3-8, and abnormal neuroimaging findings (Friedland, 2013).
Mild Traumatic Brain Injury
mTBI represents a major public health issue. Rates of hospitalized adults with
mTBIs range from 100 to 300/100,000 each year (Carroll et al., 2004). According to
epidemiological estimates put forth by the CDC, of the 1.7 million TBIs that occur
annually in the United States, the majority, 80%, are mild (Ma, Chan, & Carruthers,
2014). This incidence rate most likely understates the true occurrence impact of mTBI in
the United States as many mTBIs are treated in non-hospital medical settings, emergency
departments, or go untreated. While an individual who sustains a mTBI may only
experience brief symptoms, a significant minority of individuals experience persistent
problems. Unfortunately, the term “mild” may be a misnomer and the patient or provider
may fail to properly grasp its true impact. The consequences of mTBI on one’s life are
not, in fact, always “mild”.
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Typical Course of mTBI. In the typical course of a mTBI case, symptom and cognitive
recovery is usually achieved three months post injury (Belanger et al., 2005). While many
individuals follow the usual course of recovery, a nontrivial minority report experiencing
persistent post-concussion symptoms following a mTBI. When symptoms persistent they
are referred to as post-concussive syndrome (PCS) (Boake et al., 2005). Estimates of PCS
occurrence range widely and the etiology of this syndrome continues to be debated in the
literature (Ryan & Warden, 2009).
mTBI Symptoms
Individuals who sustain a mTBI, whether they recover as expected or are later
diagnosed with PCS, commonly report experiencing a general cluster of post-concussion
symptoms immediately following the mTBI. Post-concussion symptoms include somatic
(nausea, headache, dizziness), cognitive (poor attention, memory, and executive
function), and behavioral or emotional changes (irritability, depression, emotional
lability, anxiety) following the injury (Levin & Diza-Arrastia, 2015). While clinicians
expect these symptoms to resolve in the 12 weeks following the injury, and often do
(Levin & Diaz-Arrastia, 2015), the area of most interest to medical and mental health
providers is the population of individuals whose symptoms persist. Studies estimate 44%
of individuals may continue to experience post-concussion symptoms one year after
injury (Dikmen, Machamer, Fann, & Temkin, 2010) and 30% of patients with mTBI
experience new onset or intensification of one or more post-concussion symptoms three
months post injury (Meares et al., 2011). In looking at the types of symptoms mTBI
survivors report, Ponsford and colleagues (2011) examined mTBI and control patients in
the emergency department. Their results revealed that while both mTBI and control
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patients recovered well physically at three months post injury, patients with mTBI
reported more cognitive complaints (memory and concentration difficulties) than their
control counterparts (Ponsford, Cameron, Fitzgerald, Grant, & Mikocka-Walus, 2011).
At three months post injury, rates of post-concussion symptom prevalence have been
reported at 64% for mild to moderate TBIs (Boake et al., 2005). Dikmen and colleagues
(2010) found that as many as 44% report experiencing three or more symptoms one-year
post injury (Dikmen, Machamer, Fann, & Temkin, 2010). While these estimates of postconcussion symptoms range considerably they nonetheless highlight the significant
distress this population of mTBI survivors experiences and the negative impact these
symptoms have on the lives of mTBI injury survivors.
Following discharge from the hospital, a significant proportion of mTBI survivors
are not returning to stable employment. For those who are employed preinjury, 31% of
individuals with a mTBI were found to be unemployed at one-year post-injury (Doctor et
al., 2005). These findings contrast sharply with national expected unemployment rates
ranging from 8% to 10% for the general population (Doctor et al., 2005). Prevalence rates
of unemployment for mTBI survivors were found in one study to increase from 12%
prior to the injury to 27% following the TBI, while for control participants, the
unemployment rate increased from 5% to 16% (Edna & Cappelen, 1987). The impact of a
TBI among individuals from traditionally underserved communities is particularly
concerning. For example, Arango-Lasprilla et al., (2008) found that compared to nonHispanic Whites, individuals from ethnic/racial minority groups (Black, Hispanic, Asian,
Native American) were approximately twice as likely to be unemployed one-year post
injury. After adjusting for gender, scores on the disability rating scale at discharge,
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preinjury employment status, marital status, age, education, and cause of injury these
results remained (Arango-Lasprilla et al., 2008). Given the high prevalence rate and
persistence of symptoms following mTBI resulting in severe consequences such as
unemployment, an examination of the symptoms following mTBI is warranted. In
particular, this should be examined among traditionally underserved populations.
As previously discussed, typical acute and/or chronic symptoms following a
mTBI include deficits and dysfunction in the domains of mood, cognition, and behavior.
Mood symptoms include self-reported emotional or behavioral problems such as
increased irritability, anxiety, depression, affective lability, apathy, and/or impulsivity
(Bay & Donders, 2008). Cognitive impairments across multiple domains have been
reported including deficits in attention, memory, and executive function (Chamelian &
Feinstein, 2006). Finally, physical problems include self-reported pain, sleep disturbance,
and sensory problems such as headaches, dizziness, and visual disturbances (Wickwire et
al., 2016). The development of these symptoms can be the result of psychosocial factors,
neurobiological consequences of the injury, or a combination of both (Ponsford, Cameron
Fitzgerald, Grant, & Mikocka-Walus, 2011; Wood, 2004). Researchers note the deficits
produced by an mTBI are often more subtle and not as well understood as those of more
severe TBIs (Dikmen, Machamer, Miller, Doctor, & Temkin, 2001).
Mood Symptoms. Depression is not only one of the most common emotional
changes reported by TBI survivors, it is also one of the most frequent psychiatric disorder
diagnoses patients receive after sustaining a TBI (Bay & Donders, 2008; Jorge et al.,
2004). Depression is characterized by feelings of sadness, hopelessness, worthlessness,
and emptiness. Depression can manifest in the form of loss of interest in previously
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enjoyed activities, fatigue, concentration problems, sleep disturbances, and changes in
appetite. Thoughts about death or suicidal ideation may also be present (American
Psychiatric Association, 2013). Estimates of depression following a TBI range from 10%
to 77% and are often most prominent in the first year following a brain injury (Silver,
McAllister, & Arciniegas, 2009). TBI point prevalence rates of depression have been
reported to be 30% at one month post injury (Bombardier et al., 2010). In the year
following the injury, prevalence rates between 13% and 53% have also been reported
(Bombardier et al., 2010; Deb, Lyons, Koutzoukis, Ali, & McCarthy, 1999; Rogers &
Reid, 2007). In contrast, rates of depression in the general population range from 8% to
10% (Guillamondegui et al., 2011).
Major depression in the acute period following a mTBI is associated with patients
report of more post-concussion symptoms, psychosocial dysfunction, and psychological
distress (Rapoport, McCullagh, Streiner, & Feinstein, 2003). Patients with depression
self-report increases in the perceived severity and number of post-concussion symptoms
(Silver, McAlister, & Arciniegas, 2009). Furthermore, the patient’s perception of their
daily functioning has been shown to exacerbate depressive symptoms in this population
(Pagulyan, Hoffman, Temkin, Machamer, & Dikmen, 2008). Jorge and colleagues (2004)
found that 33% of individuals with a mTBI were diagnosed with major depressive
disorder (MDD) following their injury. Notably, of those who received an MDD
diagnosis, more than half were diagnosed in the acute period (Jorge et al., 2004). Risk
factors for depression such as prior history of depression and alcohol dependence may
increase the likelihood of recurrent episodes of depression in TBI patients (WhelanGoodinson, Ponsford, Schonberger & Johnston, 2010).
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Depression is associated with poorer recovery following TBI, yet awareness of
depression risk post-TBI among providers and patients is low. In examining symptom
reporting of depression following mTBI, Lange and colleagues (2011) found that both
depressed individuals with mTBI and depressed individuals without a history of mTBI
endorsed greater post-concussive symptoms, and more severe symptoms than individuals
with a mTBI without depression (Lange, Iverson, & Rose, 2011). Furthermore, the
authors found that 95.7% of individuals in the mTBI-depressed group met ICD-10
criteria for PCS compared to only 48.6% in the mTBI-non-depressed group. The
relationship between mood problems and reported perceived cognitive impairments is of
particular interest as well. For instance, Jorge and colleagues (2004) found that patients
with a TBI diagnosed with MDD following their injury exhibited significant impairment
on tests of executive functioning (Jorge et al., 2004). Additionally, individuals in the
depressed TBI group had smaller gray matter volume in the prefrontal cortex relative to
the non-depressed TBI group (Jorge et al., 2004) suggesting there may be a relationship
between depression, TBI, executive functioning, and pre-frontal cortex volume. In
another study examining mild to moderate TBI, self-reported symptoms of depression,
rather than cognitive complaints, were associated with poorer performance on measures
of executive function (Schiehser et al., 2011). Though notably this study did not utilize
controls and relied on participant self-report of pre and post-injury behaviors instead of
using a longitudinal design. Therefore, they trusted their participants’ ability to estimate
their preinjury behavior which may not be an accurate reflection of their actual preinjury
behavior (Schiehser et al., 2011).
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Depression symptomatology is often measured using the Beck Depression
Inventory II (BDI-II) (Beck, Steer, & Brown, 1996). The BDI-II is a 21-item self-report
measure of the intensity of depressive symptoms for individuals ages 13 to 80.
Individuals are asked to respond to statements about their mood over the past two weeks
on a 4-point scale, with the overall score obtained by summing the ratings for all items.
Scores ranging between 0 and 13 are indicative of minimal depression; scores that fall
between 14 and 19 are considered to reflect a mild level of depression; scores of 20 to 28
are considered moderate; and a score ranging from 29 to 63 is labeled severe (Beck Steer,
& Brown, 1996).
Cognitive Symptoms. While changes in mood are common following mTBI,
survivors often report experiencing a myriad of other symptoms that impact their quality
of life and daily functioning including symptoms related to changes in cognition
(Chamelian & Feinstein, 2006). Individuals with a mTBI may show deficits in a variety
of cognitive domains including executive function, memory, attention, and processing
speed (Arciniegas, Held, & Wagner, 2002; Frencham, Fox, & Maybery, 2005). Executive
functioning (EF) comprises higher-order cognitive abilities such as cognitive flexibility,
problem solving, concept formation, self-regulation, working memory, and attention. For
mild, moderate, and severe TBI survivors, deficits in this domain are common
(Frencham, Fox, & Maybery, 2005), and often result in difficulties engaging in inpatient
rehabilitation and achieving social independence upon discharge (Wood & Worthington,
2017). EF deficits can be objectively quantified using neuropsychological test
performance completed following the brain injury.
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Results from neuropsychological assessments conducted on mTBI survivors
reveal overall mild cognitive impairment following a mTBI with small effect sizes
(Belanger et al., 2005). Jurick et al. (2018) demonstrated that poorer processing speed
and attention as well as more severe psychological symptoms are associated with worse
performance on EF aspects of inhibition and set-switching in veterans with a history of
mTBI greater than three months. Further, this remained after accounting for injury
variables (Jurick et al., 2018). Another recent study found that compared to healthy
control veterans, veterans who sustained mTBIs performed significantly worse on EF
measures even after controlling for combat exposure, depression, and age (Gaines, Soper,
& Berenji, 2016).
Examining the effect of these EF impairments, a meta-analysis by Schretlen and
Shapiro (2003) examined effect sizes of studies reporting on patients with mTBIs and
patients with moderate to severe TBIs. Based on their review of 15 studies, the overall EF
effect size (Cohen’s d) for mTBI studies was d = .24 and the effect size for moderate to
severe TBIs was d = .74. Cohen (1988) defined d’s of 0.2, 0.4, and 0.8 as small, medium,
and large effect sizes, respectively. A second meta-analysis reported similar overall effect
sizes (d = .20) for EF deficits assessed in the first three months following a mTBI
(Belanger et al., 2005). Overall these meta-analyses point to small effects sizes for EF
deficits.
EF Assessment Measures
A variety of different measures have been used to assess EF impairments in mTBI
including: Delis-Kaplan Executive Function System (D-KEFS) verbal fluency and colorword interference (Jurick et al., 2018), Trail Making Test (Gaines, Soper, & Berenji,
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2016), Rey-Osterrieth Complex Figure Test (Gaines, Soper, & Berenji, 2016), Controlled
Oral Word Association Test (COWA-FAS) (Prince & Bruhns, 2017), Wisconsin Card
Sorting Test (WCST) (Prince & Bruhns, 2017). The Executive Abilities: Measure and
Instruments for Neurobehavioral Evaluation and Research (NIH-EXAMINER) (Kramer
et al., 2014) is a more recent neuropsychological assessment that aims to assess EF
deficits in a variety of neurobehavioral conditions that is efficient, modifiable, and
modular. The test is suitable for a broad range of ages and ability levels, available in
Spanish and English, and notably includes individuals with TBI in its diagnostic cohort.
The test is separated into domains of working memory, inhibition, set shifting, fluency,
planning, insight, and social cognition and behavior. Regarding the psychometric
properties of the NIH-EXAMINER, confirmatory factor analysis supports a one-factor
and a three-factor model which are the basis for the Executive Composite score as well as
subscale scores of Fluency, Working Memory, and Cognitive Control. Test-retest
reliabilities for these scales range from .78 to .93 (Kramer et al., 2014).
Given that the NIH-EXAMINER is a more recent neuropsychological assessment
measure there is a dearth of literature on its use in TBI and mTBI populations. Possin and
colleagues (2014) examined the validity and neuroanatomical correlates of the Executive
Composite score for the NIH-EXAMINER. The Executive Composite score includes
measures of set-shifting, inhibition, fluency, and working memory. The study sample
consisted of 225 mixed neurological patients and healthy controls, of which 16 has
sustained a TBI. The study did not specify if the TBIs were mild, moderate, or severe.
For their analyses, the Executive Composite score was considered to have good
ecological validity if it was found to be a significant predictor of the Frontal Systems
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Behavior Scale (FrSBe) in regression models. The results indicated the Executive
Composite score on the NIH-EXAMINER accounted for 28% of the variance in FrSBe
scores beyond age. Furthermore, the Executive Composite remained a significant
predictor after including two commonly used EF tests, the Stroop test and Trails B as
covariates (Possin, LaMarre, Wood, Mungus, & Kramer, 2014). In another study,
Gardner and colleagues (2017) examined subjective and objective cognitive functioning
in older adults with a history of TBI and concluded that their results, which showed a
lack of cognitive impairment in mTBI compared with controls, was due to poor
sensitivity of the cognitive battery chosen for the study. The study did not utilize
measures that designed to assess EF and processing speed and therefore they
recommended using the NIH-EXAMINER for future studies (Gardner, Langa, & Yaffe,
2017).
A review of the literature identifies only one study that utilized the NIHEXAMINER specifically in a TBI population. Kaup and colleagues (2017) used the NIHExaminer to assess the neuropsychological profile of TBI in older veterans. All study
participants had sustained TBIs at least one year prior, with most having sustained their
injury five years prior. Specifically, they analyzed factor scores for working memory,
fluency and cognitive control in their analyses. Overall, they found the
neuropsychological profile of older veterans with a lifetime history of TBI to be
characterized by executive dysfunction (f2 = .08) and slowed processing speed (f2 = .09).
Further, deficits associated with TBIs were most often present for individuals who had
sustained multiple mTBIs or individuals who had sustained moderate to severe TBIs.
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These EF and working memory deficits were not clearly present for veterans who
sustained only a single mTBI (Kaup et al., 2017).
Subjective Cognitive Complaints
The ability of patients to accurately report cognitive deficits following a brain
injury is of considerable clinical importance. Medical and mental health providers are
often uncertain of the best way to interpret and utilize patient self-report, as this
information, while extremely valuable, is often fraught with inconsistences. Subjective
cognitive complaints following TBI can include self-reported impairments in memory,
attention, and EF (Ponsford, Cameron, Fitzgerald, Grant, & Mikocka-Walus, 2011).
These complaints are extremely distressing as they may lead to TBI survivors
experiencing disability and prolong use of medical services. It is important to distinguish
subjective cognitive complaints from objectively measured cognitive deficits. Subjective
cognitive complaints following TBI are often only weakly related to injury severity and
cognitive complaints do not necessarily imply impairment of cognitive abilities
(Chamelian & Feinstein, 2006; Stulemeijer, Vos, Bleijenberg, & van der Werf, 2007).
Physical limitations, fatigue, and affective distress have been shown to be strongly
associated with cognitive symptom reporting (Trahan, Ross, & Trahan, 1999; Karzmark,
Hall, & Englander, 1995).
A large proportion of the variance in subjective cognitive complaint reporting
appears to be accounted for by factors that are not related to the injury. For example,
depressed mood, as previously reported, is strongly related to the presence of subjective
cognitive complaints in individuals with a mTBI (Trahan, Ross, & Trahan, 1999).
Stulemijuer and colleagues (2007) examined individuals who sustained a mTBI with and
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without cognitive complaints six months’ post injury. Thirty-nine percent of individuals
with a mTBI in their sample reported cognitive complaints. Within this group, cognitive
complaints were strongly related to emotional distress, personality, lower education level,
and poorer physical functioning but not to injury characteristics. Further, severity of selfreported cognitive complaints was unrelated to performance on neuropsychological
assessment (Stulemijuer et al., 2007). These findings raise the strong possibility that
subjective cognitive complaints may be more related to sub-acute emotional functioning
than to neuropsychological test performance. This result has implications for treatment of
mTBI using mood therapies as these findings imply that treatment of mood complaints
may lead to a reduction in subjective cognitive complaints in this population.
At present there a few measures designed for TBI populations that are used in the
reporting of subjective cognitive complaints. These measures are the Neurobehavioral
Symptom Inventory (Cicerone & Kalmar, 1995), the Frontal Systems Behavior Scale
(Grace & Malloy, 2001), and the Rivermead Post-Concussion Symptoms Questionnaire
(King, Crawford, Wenden, Moss, & Wade, 1995).
Neurobehavioral Symptom Inventory. A common measure for assessing post
concussive symptoms following TBI is the Neurobehavioral Symptom Inventory (NSI).
The NSI is a 22-item symptom checklist and each item is rated on a 5-point Likert scale
from 0 (none) to 4 (very severe) wherein the patient rates how much the symptoms have
impacted the patient in the past two weeks (Cicerone & Kalmar, 1995). Cronbach’s alpha
for the comprehensive scale was 0.95, which indicates a high degree of internal
consistency. High alphas for each of the three subscales, Somatic, Affective, and
Cognitive, are observed as well (0.88, 0.91, 0.92 respectively). There is a high degree of
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correspondence among most NSI items and the NSI total score, particularly anxiety,
forgetfulness, difficulty concentrating, and poor frustration tolerance (r = 0.80 to 0.83)
(King et al., 2012).
Frontal Systems Behavior Scale. The FrSBe is a behavior rating-scale comprised
of 46 items, designed to measure dysfunctions regarding behaviors associated with the
frontal regions of the brain (Grace & Malloy, 2001). Each item is rated on a 5-point
Likert scale from 1 (almost never) to 5 (almost always) wherein the participants rates
how they believe they were functioning before the injury and at present (after the injury).
The FrSBe yields four scores for each time point (i.e. before the injury and after the
injury): a total score, and three subscores (Apathy, Disinhibition, and Executive
Dysfunction, respectively consisting of 14, 15, and 17 items). Higher scores are
indicative of poorer self-reported functioning (Grace & Malloy, 2001). The total score
and the three subscales have shown high internal consistency, satisfactory test-retest
reliability in multiple studies Malloy & Grace, 2005). This suggests that the scales have
strong construct, discriminant, convergent, and ecological validity (Malloy & Grace,
2005). Specifically, high internal consistency has been shown in the FrSBe manual which
reports α coefficients of 0.88, 0.72, 0.75, and 0.79 for the Total, Apathy, Disinhibition,
and Executive Dysfunction scales for the self-report form in a normative sample
respectively (Grace & Malloy, 2001). Factor-analyses of the FrSBe for clinical use in a
population of patients with traumatic brain injury indicated that the total-score is an
appropriate measure when considering its psychometric properties (Niemeier, Perrin,
Holcomb, Nersessova, & Rolston, 2013). Reid-Arndt and colleagues (2007) found the
FrSBe to be a significant predictor of community integration outcomes following
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traumatic brain injury. Specifically, their results showed more executive complaints
(FrSBe Executive Dysfunction) predicted lower community integration Total Scores.
Further, they found that increased apathy (FrSBe Apathy) was associated with reduced
community integration productivity (Reid-Arndt, Nehl and Hinkebein, 2007). Normative
data for the FrSBe comes from the FrSBe Professional Manual and the normative sample
is comprised of 436 men and women ranging in age from 18 to 95 years and in education
from 10 years to doctoral level. The normative tables stratified for gender, age, and
education provide T scores (Malloy & Grace, 2005).
Rivermead Post-Concussion Symptoms Questionnaire. Another measure that is
often used to quantify TBI severity is the Post-Head Injury Symptoms Questionnaire, an
adaptation of the Rivermead Post-Concussion Symptoms Questionnaire (RPQ) (King,
Crawford, Wenden, Moss, & Wade., 1995). In this measure, TBI post-concussive
symptom severity is defined via self-report wherein individuals are asked to rate 16 postconcussive symptoms on a scale of 0 (not experienced at all) to 4 (severe problem)
(Guise et al., 2015). The 16 symptoms are divided into three subscales: cognitive (poor
concentration, poor memory, taking longer to think), emotional (depression, frustration,
irritability, restlessness), and somatic (dizziness, nausea, headache, noise sensitivity,
fatigue, sleep disturbance, blurred vision, double vision, light sensitivity). Similarly,
factor analysis of the RPQ finds a three-factor model of cognitive, emotional, and
somatic factors, with a high degree of covariation overall. The two-factor model
combined somatic and emotional factors into one factor and resulted in a similar
goodness-of-fit to the data (Potter, Leigh, Wade, & Fleminger, 2006).
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The test is divided into the RPQ-13 and the RPQ-3, with the RPQ-13 items
assessing mood, cognition, sleep, and other physical symptoms that are later symptoms of
post-concussion syndrome. The RPQ-3 items assess dizziness, headaches, nausea and/or
vomiting and are early concussion symptoms. It is recommended that analyses are
conducted separately for the RPQ-13 and the RPQ-3 because individually they
demonstrate good construct validity and test-retest reliability, which is lost when they are
combined (Eyers, Carey, Gilworth, Neumann, &Tennant, 2005). In the present study, per
recommendations from the literature, the RPQ-13 will be used to assess mTBI severity.
Sleep. Sleep disturbance is among the most common complaint individuals report
following a TBI (Wickwire et al., 2016). Alterations in sleep can develop acutely
following injury (Ponsford, Parcell, & Sinclair, 2013) or present at a later point during
the recovery process (Mantua, Mahan, Henry, & Spencer, 2015). Individuals with milder
injuries often report greater impairments in subjective and objective measures of sleep
compared to those with moderate or severe TBIs (Parcell, Ponsford, Rajaratnam, &
Redmond, 2006; Shekleton et al., 2010). Objective recordings of sleep obtained via
polysomnography (PSG) demonstrate longer sleep latency (Mantua, Henry, Garskovas, &
Spencer, 2017), hypersomnia (Imbach et al., 2016), decreased sleep efficiency (a measure
of time asleep compared to time in bed) (Shekleton et al., 2010), and increased
awakenings (Parcell, Ponsford, Redman, & Rajaratnam, 2008).
Present Study
Consequently, a question is raised, how does a clinician conceptualize and treat
patients who present with subjective cognitive complaints despite no evidence of
cognitive impairment on objective neuropsychological testing? As discussed previously,
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mood, or more specifically depressed mood, appears to be one factor that could
potentially moderate this relationship. Individuals with depression are generally expected
to have cognitive complaints, as perceived cognitive impairment is a hallmark of
depression (Channon & Green, 1999; Zakzains, Leach & Kaplan, 1998). Similarly,
depressed mood is very common following a mTBI. Individuals with depressed mood
commonly view themselves as being more emotionally, cognitively, and physically
disabled compared with their non-depressed counterparts. Clinically, this is relevant as it
has implications for treatment including when intervention is necessary following injury.
Furthermore, the ability to predict if survivors of mTBI will experience PCS or improve
would be a vital tool for clinicians.
Understanding the nature of subjective complaints in the mTBI population may be
useful for accurate diagnosis and enable providers to design treatment interventions for
individuals who experience persistent post-concussion symptoms. It is imperative we
examine the relationship between subjective cognitive complaints and objective EF
performance while taking into account depressive symptoms to better understand how
best to help this population.
The purpose of this study was to clarify the relationship among self-reported
behavioral and cognitive symptom complaints with objectively measured EF in mTBI in
a sub-acute and post-acute stages of recovery. We employed symptom (NSI, FrSBe) and
depression measures (BDI-II) in addition to a measure of mTBI symptom severity (RPQ)
and objective neuropsychological functioning measures (NIH-EXAMINER assessment
battery).
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Specific Aims and Hypotheses
Specific Aim 1: To investigate the relationship between mood, subjective cognitive
symptom complaints, and EF performance in mTBI and control participants at the subacute time point.
Hypothesis 1.1: Participants with a mTBI will report more mood complaints, more
subjective cognitive symptom complaints, and perform worse on EF measures compared
to control participants.
Hypothesis 1.2: We hypothesize presence of subjective cognitive symptom complaints
will negatively predict EF performance in both mTBI and control participants.
Hypothesis 1.3: Within the mTBI group only, symptom severity, as measured by the
RPQ-13, will be positively correlated with subjective cognitive symptom complaints and
negatively correlated with EF.
Specific Aim 2: To evaluate the role of mood in understanding group differences in EF
and subjective cognitive symptom complaints.
Hypothesis 2.1: The group differences in EF and subjective cognitive symptom
complaints are due to mood problems.
Specific Aim 3: Examine changes in mood and subjective cognitive symptom complaints
in the mTBI group over time and determine if demographic factors account for some of
the variance in this relationship.
Hypothesis 3.1: Consistent with the literature on mTBI recovery, we hypothesize
participants with a mTBI will report fewer mood complaints and fewer subjective
cognitive symptom complaints at the chronic time point compared to the sub-acute time
point.
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Hypothesis 3.2: We expect reductions in subjective cognitive symptom complaint
reporting in mTBI participants between the sub-acute and chronic time points will be
moderated by mood. We expect demographic variables, specifically ethnicity will
account for some of the variance in the relationship with mood.
METHODS
Experimental Design
The current study is a secondary analysis of data collected at The University of
New Mexico Health Sciences Center (UNMHSC). The UNMHSC Human Research
Protections Office provided IRB approval of the study and all participants provided
written informed consent. All participants were aged 18-55, were fluent in English, had
no premorbid major medical or psychiatric conditions, no history of alcohol or substance
abuse, and were not currently taking medications that interfere with cognitive
functioning, with the exception of selective serotonin reuptake inhibitors.
Participants. mTBI patients were recruited from the Departments of
Neurosurgery and Emergency Medicine from UNMHSC within two weeks following
their injury. Participants from the mTBI group had a Glasgow Coma Scale of 13-15 if
available (this information was sometimes missing from their records) and had
experienced a brief loss of consciousness following injury. Control participants included
sex- and age- matched individuals from the Albuquerque, New Mexico community. None
of the mTBI or control participants had a previous head injury.
mTBI and control participants were invited to three assessment sessions. Session
1 was scheduled from 3-14 days post-injury. Session 2 was ~2 months and Session 3 was
~4 months (this data was collected but was not be used in the present studies analysis)
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following Session 1. Participants were paid $20, $25, or $30/hour for participation in
each respective session. One acute patient was removed from analysis of the third session
for a head injury after their second session.
Questionnaires and Neuropsychological Assessments
All participants completed demographic and neuropsychological assessments in
their first session. Only participants who scored above 45 on part one of the Test of
Memory Malingering (TOMM) (Tombaugh, T. N, 1996) are included in these analyses.
The TOMM is a widely used forced choice visual recognition test designed to distinguish
between true memory impairments and malingering (Denning and Shura, 2017). TOMM
trial 1 data has been reported to have higher sensitivity and accuracy compared to TOMM
trial 2 in identifying invalid cognitive performance (Denning, 2012). Further, in mTBI
samples a cut score of approximately ≤40 provides high levels of accuracy in predicting
performance on the TOMM (Denning, 2012).
The Test of Premorbid Functioning. Participants completed the Test of
Premorbid Functioning to assess preinjury functioning (TOPF, Pearson, 2009). The
TOPF is an updated version of the Wechsler Test of Adult Reading (WTAR; Wechsler,
2001) and is standardized with the Wechsler Adult Intelligence Scale Fourth Edition
(WAIS-IV; Wechsler, 2008). The TOPF is based on a reading paradigm wherein
examinees are presented with a list of 70 words that have atypical grapheme-to-phoneme
translations and are asked to read the words aloud. Individuals are not required to have
knowledge or comprehension of word meaning (Pearson, 2009).
Symptom measures. Symptom, severity, mood, and executive functioning
questionnaires were administered in each session. Symptom related measures included
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the Neurobehavioral Symptom Inventory (NSI) (Cicerone & Kalmer, 1995) the Frontal
Systems Behavior Scale (FrSBe) (Grace & Malloy, 2001) and the Patient-Reported
Outcomes Measurement Information System (PROMIS, 2015).
Neurobehavioral Symptom Inventory (NSI). The NSI is a 22-item symptom
checklist and each item is rated on a 5-point Likert scale from 0 (none) to 4 (very severe)
wherein the patient rates how much the symptoms have impacted the patient in the past
two weeks (Cicerone & Kalmar, 1995). Cronbach’s alpha for the comprehensive scale
was 0.95, which indicates a high degree of internal consistency. High alphas for each of
the three subscales, Somatic, Affective, and Cognitive, are observed as well (0.88, 0.91,
0.92 respectively). There is a high degree of correspondence among most NSI items and
the NSI total score, particularly anxiety, forgetfulness, difficulty concentrating, and poor
frustration tolerance (r = 0.80 to 0.83) (King et al., 2012).
Frontal Systems Behavior Scale (FrSBe). The FrSBe is a behavior rating-scale
comprised of 46 items, designed to measure dysfunctions regarding behaviors associated
with the frontal regions of the brain (Grace & Malloy, 2001). Each item is rated on a 5point Likert scale from 1 (almost never) to 5 (almost always) wherein the participants rate
how they believe they were functioning before the injury and at present (after the injury).
The FrSBe yields four scores for each time point (i.e., before the injury and after the
injury): a total score, and three subscores (Apathy, Disinhibition, and Executive
Dysfunction, respectively consisting of 14, 15, and 17 items). Higher scores are
indicative of poorer self-reported functioning (Grace & Malloy, 2001). The total score
and the three subscales have shown high internal consistency, satisfactory test-retest
reliability in multiple studies Malloy & Grace, 2005). This suggests that the scales have
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strong construct, discriminant, convergent, and ecological validity (Malloy & Grace,
2005). Specifically, high internal consistency has been shown in the FrSBe manual which
reports α coefficients of 0.88, 0.72, 0.75, and 0.79 for the Total, Apathy, Disinhibition,
and Executive Dysfunction scales for the self-report form in a normative sample
respectively (Grace & Malloy, 2001). Factor-analyses of the FrSBe for clinical use in a
population of patients with traumatic brain injury indicated that the total-score is an
appropriate measure when considering its psychometric properties (Niemeier, Perrin,
Holcomb, Nersessova, & Rolston, 2013). Reid-Arndt and colleagues (2007) found the
FrSBe to be a significant predictor of community integration outcomes following
traumatic brain injury. Specifically, their results showed more executive complaints
(FrSBe Executive Dysfunction) predicted lower community integration Total Scores.
Further, they found that increased apathy (FrSBe Apathy) was associated with reduced
community integration productivity (Reid-Arndt, Nehl, & Hinkebein, 2007). Normative
data for the FrSBe comes from the FrSBe Professional Manual and the normative sample
is comprised of 436 men and women ranging in age from 18 to 95 years and in education
from 10 years to doctoral level. The normative tables stratified for gender, age, and
education provide T scores (Malloy & Grace, 2005).
Patient-Reported Outcomes Measurement Information System (PROMIS). The
PROMIS is a National Institute of Health Roadmap initiative that is designed to develop
self-report measures to assess well-being and functioning in the mental, physical, and
social domains of health (Hays, Spritzer, Schalet, & Cella, 2018). The PROMIS Network
develops and tests large banks of items related to health and researchers in turn select
domains of functioning that related to their specific research question. The PROMIS is
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designed to be used across all medical populations. The PROMIS-29 Profile v1.0
(PROMIS, 2015) assess seven health-related quality of life domains: physical
functioning, anxiety, depression, fatigue, sleep disturbance, satisfaction with participation
in social roles, pain interference, and pain intensity. Each domain provides separate
specific instructions for score rankings. The physical functioning domain is ranked on a
5-point scale from 1 (without any difficulty) to 5 (unable to do) and does not provide a
time frame. Participants are instructed to respond to the remainder of the questions in
terms of their functioning over the past seven days. Questions related to anxiety and
depression are ranked on a 5-point scale from 1 (never) to 5 (always). The domains of
fatigue, sleep disturbance, satisfaction of social role, and pain interference are ranked 1
(not at all) to 5 (very much). Within the sleep disturbance domain, one question referring
to sleep quality is ranked 1 (very poor) to 5 (very good). Pain intensity is ranked on a 10point scale from 0 (no pain) to 10 (worst pain imaginable). In this study we examined the
sleep disturbance, pain intensity, and pain interference scores as the captured additional
information on the domains of sleep and pain that were not available in the NSI or FrSBe.
Sleep disturbance, as previously discussed, is one of the most common complaints
following a mTBI (Wickwire et al., 2016).
Rivermead Post-Concussion Symptoms Questionnaire (RPQ). mTBI severity
was reported using the Post-Head Injury Symptoms Questionnaire that was adapted from
the Rivermead Post-Concussion Symptoms Questionnaire (RPQ) (King, Crawford,
Wenden, Moss, & Wade., 1995). In this measure, TBI post-concussive symptom severity
is defined via self-report wherein individuals are asked to rate 16 post-concussive
symptoms on a scale of 0 (not experienced at all) to 4 (severe problem) (Guise et al.,
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2015). The 16 symptoms are divided into three subscales: cognitive (poor concentration,
poor memory, taking longer to think), emotional (depression, frustration, irritability,
restlessness), and somatic (dizziness, nausea, headache, noise sensitivity, fatigue, sleep
disturbance, blurred vision, double vision, light sensitivity). Similarly, factor analysis of
the RPQ finds a three-factor model of cognitive, emotional, and somatic factors, with a
high degree of covariation overall. The two-factor model combined somatic and
emotional factors into one factor and resulted in a similar goodness-of-fit to the data
(Potter, Leigh, Wade, & Fleminger, 2006).
The test is divided into the RPQ-13 and the RPQ-3, with the RPQ-13 items
assessing mood, cognition, sleep, and other physical symptoms that are later symptoms of
post-concussion syndrome. The RPQ-3 items assess dizziness, headaches, nausea and/or
vomiting and are early concussion symptoms. It is recommended that analyses are
conducted separately for the RPQ-13 and the RPQ-3 because individually they
demonstrate good construct validity and test-retest reliability, which is lost when they are
combined (Eyres, Carey, Gilworth, Neumann, & Tennant, 2005). In the present study, per
recommendations from the literature, the RPQ-13 will be used to assess mTBI severity.
Beck Depression Inventory-II (BDI-II). The Beck Depression Inventory (BDI-II)
was administered as the mood measure in this study (Beck et al., 1996). The BDI-II is a
21-item self-report measure of the intensity of depressive symptoms for individuals ages
13 to 80. Individuals are asked to respond to statements about their mood over the past
two weeks on a 4-point scale, with the overall score obtained by summing the ratings for
all items. Scores ranging between 0 and 13 are indicative of minimal depression; scores
that fall between 14 and 19 are considered to reflect a mild level of depression; scores of
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20 to 28 are considered moderate; and a score ranging from 29 to 63 is labeled severe
(Beck et al., 1996).
Executive Abilities: Measure and Instruments for Neurobehavioral Evaluation
and Research (NIH-EXAMINER). EF was measured using the Executive Abilities:
Measure and Instruments for Neurobehavioral Evaluation and Research (NIHEXAMINER) (Kramer et al., 2014.) Analyses were conducted using the Executive
Composite from the NIH-EXAMINER as well as the three factor measures provided by
the test: the Fluency Factor, Cognitive Control Factor, and the Working Memory Factor.
The EXAMINER aims to assess EF deficits in a variety of neurobehavioral conditions
and is designed to be efficient, modifiable, and modular. The test is suitable for a broad
range of ages and ability levels, available in Spanish and English, and notably includes
individuals with TBI in its diagnostic cohort. The test is separated into domains of
working memory, inhibition, set shifting, fluency, planning, insight, and social cognition
and behavior. Regarding the psychometric properties of the NIH-EXAMINER,
confirmatory factor analysis supports a one-factor and a three-factor model which are the
basis for the executive composite score as well as subscale scores of Fluency, Working
Memory, and Cognitive Control. Test-retest reliabilities for these scales range from .78 to
.93 (Kramer et al., 2014).
Attrition. While the control group had relatively stable enrollment, the sub-acute
mTBI group suffered from attrition, with about ¾ of participants returning for the second
session. The consort diagram is shown in Figure 1.
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Statistical Analyses
Data analysis was conducted using IBP SPSS version 23. SPSS Explore was used
to detect extreme outliers and examine the distribution characteristics of all variables.
At the sub-acute time point, four variables relating to subjective symptom
reporting (NSI emotion, NSI cognitive, NSI somatic, FrSBe total) were factor analyzed
using principal component analysis with Direct Oblimin rotation. This analysis yielded
one factor explaining a total of 78.56% of the variance for the entire set of variables. This
factor was termed the Symptom Composite PC factor. This procedure was repeated for
the chronic time point, again using the four subjective symptom reporting variables
measured at the chronic time point. The second analysis yielded one factor explaining a
total of 75.08% of the variance for the entire set of variables. This factor was reported as
the Symptom Composite PC factor at the chronic time point. The Symptom Composite
PC variables at the two time points were highly correlated (r(63) = .69, p <.001).
Symptom Composite PC z-scores were transformed into standard scores at both
time points. Similarly, Executive Composite, Fluency Factor, Cognitive Control, and
Working Memory scores were transformed into standard scores for ease of interpretation.
Specific Aim 1. A series of two-way ACNOVA’s were conducted to evaluate the
relationship between mood, subjective cognitive symptom complaints, and EF
performance in mTBI and control participants at the sub-acute time point. Pearson
correlations were computed to examine the associations between subjective cognitive
symptom complaints and EF performance in both mTBI and control participants.
Additional Pearson correlations examined the relationship between mTBI symptom
severity and subjective cognitive symptom complaints and correlations with EF.
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Specific Aim 2. To evaluate the role of mood in understanding group differences
in EF and subjective cognitive symptom complaints we computed a two-way ANCOVA
with the Executive Composite at the sub-acute time point as the dependent variable,
gender as a fixed factor and covariates of TOPF, BDI-II at the sub-acute time point,
Symptom Composite PC at the sub-acute time point.
Specific Aim 3. A series of Repeated Measures ANCOVA’s were conducted to
examine changes in mood and subjective cognitive symptom complaints in the mTBI
group over time and determine if demographic factors, specifically ethnicity account for
some of the variance in the relationship with mood. Six Repeated Measures ANCOVA’s
with a Greenhouse-Geisser correction were run with TOPF as a covariate and group and
gender as between subjects factors for each of the relevant variables (BDI-II, Symptom
Composite PC, and Executive Composite, Fluency Factor, Cognitive Control Factor, and
Working Memory Factor) to establish if results changed between the sub-acute and
chronic time points. The models examined main effects and interactions. Pearson
correlations were run to assess the role of TOPF in the models. To address the ethnicity
component of this aim we computed an additional Repeated Measures ANCOVA for the
BDI-II at the sub-acute time point with a Greenhouse-Geisser correction. TOPF and
ethnicity were selected as covariates and group and gender were between-subjects
factors.
RESULTS
Demographic Characteristics
The demographic data for the mTBI and control groups are presented in Table 1
and Table 2. The 84 individuals who participated in the study included more men than
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women, although the difference did not reach statistical significance. The majority
identified themselves as Non-Hispanic White (NHW) with Hispanic being the second
most prominent group. A majority of the individuals reported earning their high school
diploma/GED or continuing onto higher education. In both groups, most of the
individuals were currently employed with a larger proportion of individuals who
identified as unemployed or disabled in the mTBI group than in the control group. The
average age of individuals was 29.20 years (SD = 10.32). Similarly, the average age for
individuals in the mTBI group was 28.96 years (SD = 10.24) and 29.59 years (SD=10.60)
for individuals in the control group. With regard to time since the injury, the mTBI group
was assessed within two weeks of sustaining their injury (X̄= 9.92 days, SD = 3.22). The
majority, 84.5%, of participants were assessed between eight- and fourteen-days post
injury.
mTBI Injury Characteristics
For descriptive purposes, we next report only on individuals who had sustained a
mTBI. Quantifying mTBI participants by mechanism of injury, the largest proportion of
individuals sustained their mTBI in a motor vehicle accident, approximately 52% (Figure
2). Stratifying mechanism of injury by gender in Table 5, a chi square test indicated no
significant association between gender and mechanism of injury (2(3, N = 52) = 5.10, p
= .16). Both female and male participants were equally injured by assault, motor vehicle
accident, fall and sports-related injuries. A one-way ANOVA was conducted to examine
the role of the ethnicity variable in mTBI. In the mTBI sample, severity ratings as
measured by the Rivermead Post Concussive Symptom Questionnaire (RPQ-13) were not
significantly different between NHW and Hispanic participants, F(1,49) = .81, p = .37.
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Sleep disturbance ratings and pain ratings from the PROMIS were explored in the
mTBI group, as these symptoms are common after mTBI. The two pain measures
selected from the PROMIS were pain intensity and pain interference. Pain intensity refers
to the severity of pain rated on a 10-point scale from no pain to worst imaginable pain.
Pain interference refers to the degree to which pain interferes or limits an individual’s
mental, physical and social activities. BDI-II, pain intensity, pain interference, and sleep
disturbance scores were found to be very highly correlated at the sub-acute time point,
Table 3.
In the mTBI group, subjective symptom reporting measures (NSI somatic, NSI
emotion, NSI cognitive, FrSBe total after score) positively correlated with reports of
sleep disturbance, pain intensity and pain interference, see Table 4. The Executive
Composite score did not significantly correlate with any of the subjective symptom
reporting measures or reports of sleep disturbance, pain interference, or pain intensity
(Table 4). One-way ANOVAs found that mTBI participants experienced significantly
greater levels of sleep disturbance compared to control participants, F(1,82) = 18.88, p <
.01. Similarly, mTBI participants reported significantly greater levels of pain interference
(F(1,82) = 45.87, p < .01) and pain intensity (F(1,82) = 78.72, p < .01) compared to
control participants.
Measures
Outliers. SPSS Explore procedure was used to identify extreme outliers in the
data sample for the mood, symptom, and executive functioning variables. No extreme
outliers were found in the data set and therefore no additional procedures were
implemented.
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Relationships among subjective symptom reporting measures. The
relationship among the subjective symptom reporting measures, specifically the NSI and
the FrSBe, were examined to determine if data reduction was justified. As previously
discussed, both of these measures, the NSI and FrSBe, were originally designed to
capture TBI symptom sequelae and therefore appeared to be most relevant in addressing
our hypotheses about subjective symptom reporting. Both the NSI and FrSBe assess
participants perceived mTBI symptoms and measure complimentary functioning
impairments.
In the entire sample, Pearson correlations among the symptom report measures
were computed at the sub-acute time point. The NSI is comprised of three sub-scores,
somatic, cognitive, and emotional and one total score. The somatic score is highly
positively correlated with the cognitive (r(83) = .85, p < .01) and emotional scores (r(83)
= .82, p < .01). The cognitive score is similarly highly correlated with the emotional
score, r(83) = .86, p < .01. As expected, all three sub-scores are also highly correlated
with the total score with the values ranging from r =. 93 to r = .96, see Table 7. High
intercorrelations were also found between the NSI total score and FrSBe total after scores
(r(83) = .59, p < .01).
The BDI-II was examined in relation to the subjective symptom reporting
measures because the BDI-II, like the NSI and FrSBe, assesses symptoms that may
present following a mTBI. Pearson correlations of the BDI-II, NSI total score, and
FrSBe were computed and the BDI-II was found to correlate with the NSI total score
(r(38) = .75, p < .01) and FrSBe (r(84) = .59, p < .01). While significant correlations were

31

found between symptom and BDI-II measures, we decided to characterize the BDI-II
separately as a mood measure.
The BDI-II was next examined to determine the percentage of participants in the
entire sample and in the respective groups who met the BDI-II criteria for experiencing
minimal (0-13), mild (14-19), moderate (20-28), and severe depression symptoms (2963). In the entire sample, 67.4% of participants reported experience minimal depression
symptoms, 14% mild, 8.1% moderate, and 8.1% severe depression symptoms. In the
mTBI group 59.6% reported minimal depression symptoms, 17.3% mild, 9.6% moderate,
and 13.5% severe depression symptoms. In the control group the largest percentage,
84.4% reported minimal depression symptoms, 9.4% mild, and 6.3% moderate, and no
participants in the control group reported experiencing severe depressions symptoms (see
Figure 3). BDI-II scores at the sub-acute and chronic time points for mTBI and control
participants is presented in Figure 5.
Relationships among neuropsychological assessment measures. Relationships
between the neuropsychological measures used in this study were examined to provide
support for inclusion or exclusion of variables in the analyses that follow.
Neuropsychological measures included the NIH-EXAMINER and the Test of Premorbid
Functioning (TOPF). Pearson correlations among the executive functioning measures
were computed to examine relationships among these measures to provide justification
for use of the executive composite score in the analyses. The NIH-EXAMINER provides
four scores, a fluency factor, cognitive control factor, a working memory factor, and
executive composite score. As expected, the fluency (r(76) = .80, p < .01), cognitive
control (r(76) =.62, p < .01) and working memory factors (r(76) = .66, p < .01) are highly
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correlated with the executive composite score, see Table 8. The cognitive control and
working memory factors are correlated (r(76) = .31, p = .006) and the fluency factor is
correlated with the working memory factor (r(76) = .34, p = .002). Notably, the fluency
factor is not correlated with the cognitive control factor r(76) = .192, p = .096. Given that
the NIH-EXAMINER provides the executive composite and we reported high
intercorrelations it was deemed appropriate for use in the following analyses.
Following we examined the TOPF standard score as a possible covariate in our
Repeated Measures analyses. One would expect the TOPF standard score would be
strongly positively related to years of education and cognitive test scores. Pearson
correlations found the TOPF total standard score correlated with years of education (r(83)
= .463, p < .01). Independent t-tests (Table 6) revealed significant group differences in
TOPF performance between the mTBI and control groups with control participants
earning higher scores compared to those who sustained a mTBI. A histogram of TOPF
scores by group is presented in Figure 7. Given these findings, the TOPF was selected as
a covariate to address our hypotheses using Repeated Measures analyses.
Group differences. The assessment measures used in the analyses that follow are
presented in Table 6. For descriptive purposes we also report independent samples t-tests
between both groups at the sub-acute time point. In comparing mTBI and control
participants, individuals with a mTBI had significantly higher scores on the BDI-II, all
symptom variables, and the Symptom Composite PC. Similarly, control participants
showed significantly higher scores on the executive composite score and the fluency
factor. No significant difference was found between the cognitive control or working
memory factors from the NIH-EXAMINER. Overall, participants with a mTBI had
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higher rates of depressive and subjective symptom complaints compared to healthy
controls, and healthy controls had slightly better overall executive functioning
performance compared to mTBI participants.
Data Reduction. Given the high intercorrelations between the symptom variables
(NSI emotion, NSI cognitive, NSI somatic, FrSBe total), these four variables were
analyzed using principal components analysis with Direct Oblimin rotation. This analysis
yielded one factor explaining a total of 78.56% of the variance for the entire set of
variables. This factor was termed the Symptom Composite PC factor. This procedure was
repeated for the chronic time point, again using the four subjective symptom reporting
variables measured at the chronic time point. The second analysis yielded one factor
explaining a total of 75.08% of the variance for the entire set of variables. This factor was
reported as the Symptom Composite PC factor at the chronic time point. The Symptom
Composite PC variables at the two time points were highly correlated (r(63) = .69, p
<.01).
Follow-up Pearson correlations were computed between the Symptom Composite
PC variable and the mood and symptom variables. As expected, the Symptom Composite
PC score is significantly correlated with the symptom variables, NSI total score (r(83) =
.976, p < .01) and the FrSBe total score (r(83) =.742, p < .01). The composite variable is
also highly correlated with BDI-II, r(84)= .798, p < .01.
Cultural Considerations
Cultural expressions of emotional functioning, symptom reporting, and
performance on executive functioning measures may influence the outcome of a mTBI,
therefore ethnicity was examined in the entire sample at the sub-acute time point.
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Assessment of the relevance of ethnicity is complicated by the variety of ethnic labels
participants chose to describe themselves. For the current study we collapsed ethnic
variation into two categories, NHW and Hispanic. Thus, two-way ANOVAs (group,
ethnicity) were computed for the BDI-II, NSI somatic, NSI cognition, NSI emotion,
FrSBe, Symptom Composite PC, Executive Composite, Fluency Factor, Cognitive
Control Factor, and Working Memory Factor at the sub-acute time point for all
participants.
Main group effects for ethnicity were found for the BDI-II (F(1, 83) = 10.60, p =
.002, η2 = .12), NSI somatic (F(1,82) = 22.84, p < .001, η2 = .22), NSI cognition (F(1,82)
= 15.70, p < .01, η2 = .17), NSI emotion (F(1,82) = 13.34, p < .01, η2 = .14), FrSBe
(F(1,83) = 6.37, p = .01, η2 = .07), Symptom Composite PC (F(1,82) = 19.85, p < .01, η2
= .20), Executive Composite (F(1,75) = 7.60, p = .007, η2 = .10), and the Fluency factor
(F(1,75) = 8.59, p = .005, η2 = .11). No significant main effects were found for the
Cognitive Control factor (F(1, 75) = 2.82, p = .10, η2 = .04) or Working Memory factor
(F(1,75) = . 06, p = .80, η2 = .00). Importantly, no group by ethnicity interactions were
found for the BDI-II (F(1,83) = .01, p = .97, η2 = .00), NSI somatic (F(1,82) = .19, p =
.66, η2 = .00), NSI cognition (F(1,82) = .61, p = .44, η2 = .01), NSI emotion (F(1,82) =
.29, p = .59, η2 = .00), FrSBe (F(1,83) = 1.09, p = .30, η2 = .01), Symptom Composite PC
(F(1,82) = .02, p = .90, η2 = .00), Executive Composite (F(1,75) = .89, p = .35, η2 = .01),
Fluency factor (F(1,75) = .02, p = .89, η2 = .00), Cognitive Control factor (F(1,75) = 2.82,
p = .10, η2 = .04), and Working Memory factor (F(1,75) = .06, p = .80, η2 = .00).
Additional two-way ANOVA’s on sleep and pain measures from the PROMIS
revealed no significant interactions between group and ethnicity for sleep disturbance
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(F(1,82) = 2.21, p = .14, η2 = .03), pain intensity (F(1,82) = 1.82, p = .18, η2 = .02), or
pain interference (F(1,82) = .57, p = .45, η2 = .01).
Statistical Analyses
Hypothesis 1a. A series of two-way ANCOVA’s were conducted to evaluate if
mTBI participants reported more mood complaints, more subjective cognitive symptom
complaints, and performed worse on EF measures compared with control participants at
the sub-acute time point. As previously reported, univariate t-tests revealed significant
differences for all relevant variables except for the Cognitive Control Factor and Working
Memory Factor at the sub-acute time point, see Table 6. To determine if both variables
could be included in the same model, a Pearson correlation was computed for the BDI-II
and Symptom Composite PC at the sub-acute time. The Pearson correlation revealed a
highly significant positive correlation (r(83) = .80, p < .01). Given this result it was
determined the models should be run separately to avoid problems due to
multicollinearity.
Model 1.1: Mood as measured by the BDI-II. Differences in scores on the BDI-II
between the two participant groups at the sub-acute time point were assessed in model
one. We hypothesized individuals who sustained a mTBI would report more negative
mood complaints, as measured by the BDI-II, compared to control participants. A twoway ANCOVA with TOPF as a covariate and group and gender as between-subjects
factors was conducted to address the mood component of Hypothesis 1a. Betweensubjects effects revealed a significant main effect of group, F(1,82) = 4.69, p < .01, η2 =
.19, indicating the mTBI group reported experiencing significantly more distress than the
control group at the sub-acute time point. This finding provides support for the mood
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component of Hypothesis 1a. A significant positive main effect of TOPF was revealed
F(1,82) = 4.69, p = .03, η2 = .06. No other main effects or interactions were significant.
Model 1.2: Subjective Symptom Complaints as measured by the Symptom
Composite PC. Model 1.2 explored whether mTBI and control participants differed in
terms of cognitive symptom complaint reporting. A two-way ANCOVA with TOPF as a
covariate and group and gender as between-subjects factors was conducted to address the
subjective symptom reporting component of Hypothesis 1a. Analyses revealed a
significant between-subjects main effect of group, F(1,81) = 27.07, p < .01, η2 = .26.
mTBI participants reported experiencing significantly more symptom distress compared
to control participants providing support for the symptom component of Hypothesis 1a.
No other between-subjects effects were significant.
Model 1.3: Executive Functioning as measured by NIH-EXAMINER Executive
Functioning Composite. The next model aimed to examine the role of EF, as measured
by the NIH-EXAMINER, between the mTBI and control participants. We proposed
mTBI participants would earn lower EF scores compared to their control counterparts.
The preceding two-way ANCOVA was repeated for the Executive Composite. No
between group differences were found in EF performance between mTBI and control
participants (F(1,74) = 1.19, p = .28, η2 = .02). Notably, while the univariate t-test was
significant for the Executive Composite, the current analysis was not significant and
therefore does not provide support for Hypothesis 1a. Given mixed findings for the NIHEXAMINER Executive Composite, it was deemed necessary to examine the respective
components of the composite individually, in the following models. A significant main
effect of TOPF, F(1,74) = 44.42, p < .01, η2 = .39 was revealed in this analysis.
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Individuals with higher premorbid intelligence had higher EF scores. No other group
effects were found to be significant.
Model 1.4: Fluency Factor of the NIH-EXAMINER. Given the mixed findings
in model 1.3, three additional two-way ACNOVA’s were computed to examine the role
of the three factors that comprise the Executive Functioning Composite. Model 1.4
explored the Fluency Factor. We hypothesized individuals with a mTBI would score
lower on the Fluency Factor measure compared to controls. Analogous to the preceding
model, no between group differences were found in performance on the Fluency Factor
between mTBI and control participants (F(1, 74) = 3.45, p = .07, η2 = .05). Similar to
model 1.3 a significant main effect of TOPF, F(1,74) = 24.37, p < .01, η2 = .26 was
revealed in this analysis. Individuals with higher premorbid intelligence had higher EF
scores. No other group effects were found to be significant. The findings of this analysis
do not provide support for Hypothesis 1a.
Model 1.5: Cognitive Control Factor of the NIH-EXAMINER. Model 1.5
explored the Cognitive Control Factor. As before, we expected participants with a mTBI
would score lower on the Cognitive Control Factor compared to control participants.
Analyses again revealed no between group differences in performance on the Cognitive
Control Factor (F(1,74) = .21, p = .65, η2 = .00) but did reveal a significant main effect of
TOPF, F(1,74) = 6.30, p = .01, η2 = .08. No other group effects were found to be
significant. The findings of this analysis do not provide support for Hypothesis 1a.
Model 1.6: Working Memory Factor of the NIH-EXAMINER. The final model
of Hypothesis 1a examined the Working Memory Factor. Similar to the preceding two
models, analyses revealed no between-subjects group differences in performance on the
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Working Memory Factor (F(1,74) = .003, p = .95, η2 = .00). A significant main effect of
TOPF was again present, F(1,74) = 10.13, p = .002, η2 = .13). No other group effects
were revealed to be significant. Again, these findings do not provide support for
Hypothesis 1a.
Hypothesis 1a overall findings. Analyses revealed significant between-subjects
effects for the BDI-II and Symptom Composite PC. No significant between-subjects
group effects were found for the Executive Composite, Fluency Factor, Cognitive
Control Factor, or Working Memory Factor. Therefore, these results do not provide
support for Hypothesis 1a. mTBI participants reported significantly more mood
complaints and more subjective cognitive symptoms than control participants at the subacute time point. In contrast, no significant differences in EF performance was found
between the two groups.
Hypothesis 1b. We hypothesized that the presence of subjective cognitive
symptom complaints, as measured by the Symptom Composite PC, will negatively
predict EF performance in both mTBI and control participants. It was expected that the
presence of more symptoms would result in poorer performance on objective
neuropsychological assessment measures. While these variables were found to be
negatively correlated, they did not reach significance (r(75) = -. 07, p = .52). Therefore,
Hypothesis 1.b was not supported.
Hypothesis 1c. Pearson correlations were conducted to assess if severity of the
mTBI, as measured by the RPQ-13, was positively correlated with subjective cognitive
symptom complaints and negatively correlated with EF. As expected, Pearson
correlations revealed the severity rating positively correlated with the Symptom
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Composite PC at the sub-acute (r(50) = .81, p < .01) and chronic time point (r(36) = .57,
p < .01), indicating that the severity of the mTBI was related to subjective symptom
complaint reporting. In contrast, Pearson correlations of severity and the Executive
Composite were not significantly positively correlated at the sub-acute (r(46) = .19, p =
.20) or chronic time points (r(32) = .30, p = .09). Therefore, Hypothesis 1c was not
supported.
Hypothesis 2. We proposed the group differences in EF and subjective cognitive
symptom complaints are due to mood problems. A two-way ANCOVA was computed
with the Executive Composite at the sub-acute time point as the dependent variable,
gender and group as fixed factors, and with covariates of TOPF, BDI-II at the sub-acute
time point, Symptom Composite PC at the sub-acute time point. Between-subjects effects
were revealed to be nonsignificant for the BDI-II (F(1,73) = .17, p = .68, η2= .002) and
Symptom Composite PC (F(1,73) = .02, p = .88, η2 = .00) but were significant for the
TOPF (F(1,73) = 57.56, p < .01, η2 = .45). This process was repeated at the chronic time
point and yielded similar results. A significant main effect of TOPF was found (F(1,73) =
25.53, p < .01, η2 = .35), but no other between-subjects effects were significant. Overall,
participants EF scores did not change relative to their mood or subjective symptom
reporting. Hypothesis 2 was not supported.
Hypothesis 3a. Consistent with the literature on mTBI recovery, we hypothesized
participants with a mTBI would report fewer mood complaints and fewer subjective
cognitive symptom complaints at the chronic time point compared to the sub-acute time
point. To assess change over time for our relevant variables, we began by determining if
within group differences in performance were present for each group across the two time

40

points. Following we assessed for between-subjects effects. Consistent with the statistical
procedure implemented in Hypothesis 1a the models were run separately to avoid
inflation due to multicollinearity.
Model 3.1: Mood as measured by the BDI-II. We hypothesized individuals who
sustained a mTBI would report fewer mood complaints at the chronic time point
compared to the sub-acute time point as we expected their mood to improve over time. A
Repeated Measures ANCOVA with a Greenhouse-Geisser correction was computed with
TOPF as a covariate and group and gender as between-subjects factors to address the
mood component of Hypothesis 3a.
a. Examining within-subjects effects, a significant main effect of time, F(1,59) =
7.07, p = .01, η2 = .12, was found, indicating mTBI participants mood changed
slightly over time (Figure 4). Analyses revealed no significant interactions. The
time by group interaction (F(1,59) = 1.93, p = .17, η2 = .03) and time by gender
interaction (F(1,59) = .00, p = .99, η2 =.00) was not significant. Further, the threeway interaction between time, group, and gender was not significant (F(1,59) =
.41, p = .52, η2 = .01). Analyses revealed a significant time by TOPF interaction
(F(1,59) = 6.36, p = .01, η2 = .09). Premorbid intellectual ability was differently
related to mood at the two time points. To clarify the role of the TOPF in this
analysis, a median split of TOPF was computed at the sub-acute time point. A
one-way ANOVA with group and TOPF median split as fixed factors revealed a
significant main effect of group, F(1,82) = 8.58, p = .004, η2 = .10, see Figure 6.
b. Regarding between-subjects effects, there was a significant main effect of group,
F(1,59) = 12.11, p = .001, η2 = .17, indicating that the mTBI group had
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significantly greater (worse) mood scores than the control group at both time
points. No other between-subjects effects were found to be significant.
Model 3.2: Subjective Symptom Complaints as measured by the Symptom
Composite PC. Model 3.2 examined whether subjective cognitive symptom reporting
would change over time for mTBI participants. A Repeated Measures ANCOVA with a
Greenhouse-Geisser correction was computed with TOPF as a covariate and group and
gender as between-subjects factors.
a. Within-subjects effects revealed a significant main effect of time (F(1,57) = 7.65,
p = .008, η2 = .12), indicating overall participants reported less subjective
symptom complaints at the chronic time point, Figure 8. Within the groups, a time
by group interaction was found, F(1,57) = 4.82, p = .032, η2 =.08. No time by
gender interaction was found, F(1,57) = .002, p = .99, η2 =.00 and a three-way
interaction between time, group, and gender was found to not be significant,
F(1,57) = 1.11, p = .32, η2 = .02. A significant time by TOPF interaction was
found, F(1,57) = 7.25, p = .01, η2 = .11, indicating that premorbid intellectual
ability was differently related to symptom reporting at the two time points. This
finding resembles the effect found in Model 3.1 and is expected given the high
correlation between the BDI-II and the Symptom Composite PC.
b. Regarding between-subjects effects, there was a significant main effect of group
(F(1,57) = 13.20, p = .001, η2 = .19). Participants reported experiencing more
subjective cognitive symptom complaints than did control participants at both
time points, see Figure 8. No other between-subjects effects were found to be
significant.
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Model 3.3: Executive Functioning as measured by NIH-EXAMINER Executive
Functioning Composite. The third model examined change over time in EF performance,
as measured by the NIH-EXAMINER Executive Composite for mTBI participants. We
proposed that Executive Composite scores would improve over time. A Repeated
Measures ANCOVA with a Greenhouse-Geisser correction was computed with TOPF as
a covariate and group and gender as between-subjects factors.
a. With regard to within-subjects effects, a significant main effect of time, F(1,49) =
4.50, p = .039, η2 = .08, was found, indicating that Executive Composite scores
improved overall across the two time points, Figure 9. The time by group
interaction was not significant, F(1,49) = .10, p = .75, η2 = .002. Further there was
no time by TOPF interaction within each group, F(1,49) = 3.66, p = .06, η2 = .17,
indicating that within each group the participants scores on the TOPF did not
impact EF as measured by the Executive Composite score. No time by gender
interaction was found, F(1,49) = .02, p = .88, η2 =.000 and a three-way interaction
between time, group, and gender was found to not be significant, F(1,49) = .001,
p = .98, η2 = .00.
b. Between-subjects effects were not significant for group F(1,49) = .26, p = .61, η2
= .005. The partial eta squared value was converted into Cohen’s d for
comparison to the literature estimates of EF effect size, d = .14. There was a
significant main effect of TOPF, F(1,49) = 31.30, p < .01, η2 = .39, indicating
individuals with higher premorbid intelligence received higher EF scores. No
other group effects were found to be significant, Figure 9.
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To further assess the findings in Model 3.3, three additional Repeated Measures
ANCOVA’s were computed for the three factors that make up the Executive Composite,
the Fluency Factor, Cognitive Control Factor, and the Working Memory Factor.
Model 3.4: Fluency Factor of the NIH-EXAMINER. Model 3.4 explored change
over time in performance on the Fluency Factor. We hypothesized individuals with a
mTBI would earn higher scores on the Fluency factor at the chronic time point compared
to the sub-acute time point. As before, a Repeated Measures ANCOVA with a
Greenhouse-Geisser correction was computed with TOPF as a covariate and group and
gender as between-subjects factors.
a. No main effect of time was found, F(1,49) = 1.05, p = .31, η2 = .02, Figure 9.
Within each group, the time by group interaction was found to be significant
F(1,49) = 4.43, p = .04, η2 = .08. Therefore, overall there was an improvement in
fluency scores at the chronic time point. There was no time by TOPF interaction
within each group, F(1,49) = .61 p = .44 η2 = .01, indicating overall the
participants scores on the TOPF did not impact fluency factor scores. No time by
gender interaction was found, F(1,49) = .07, p = .79, η2 =.00 and a three-way
interaction between time, group, and gender was found to not be significant,
F(1,49) = 3.00, p = .09, η2 = .06.
b. Regarding effects between the mTBI and control participants, group was not
significant, F(1,49) = .61, p = .44, η2 = .012, d = .22. There was a significant main
effect of TOPF, F(1,49) = 14.185, p < .01, η2 = .224, indicating individuals with
higher premorbid intelligence had higher fluency factor scores. No other betweensubjects effects were found to be significant, Figure 9.
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Model 3.5: Cognitive Control Factor of the NIH-EXAMINER. Model 3.5
examined change over time of the Cognitive Control Factor of the NIH-EXAMINER. We
hypothesized that Cognitive Control Factor scores would improve at the chronic time
point for mTBI participants. We again computed a Repeated Measures ANCOVA with a
Greenhouse-Geisser correction with TOPF as a covariate and group and gender as
between-subjects factors.
a. No within-subjects main effects or interactions were found for the Cognitive
Control Factor.
b. Between-subjects effects revealed group was not significant, F(1,49) = .47, p =
.49, η2 = .01, d = .20. There was a significant main effect of TOPF, F(1,49) =
8.33, p = .006, η2 = .14, indicating individuals with higher premorbid intelligence
had higher Cognitive Control Factor scores. No other between-subjects effects
were found to be significant, Figure 11.
Model 3.6: Working Memory Factor of the NIH-EXAMINER. Model 3.6
examined whether scores on the Working Memory Factor from the NIH-EXAMINER
would change over time for mTBI participants. We again ran a Repeated Measures
ANCOVA with a Greenhouse-Geisser correction with TOPF as a covariate and group
and gender as between-subjects factors.
a. No within-subjects main effects or interactions were found for the cognitive
control factor.
b. Regarding effects between the mTBI and control participants, group was not
significant, F(1,49) = .44, p = .51, η2 = .009, d = .19. There was a significant main
effect of TOPF, F(1,49) = 9.93, p < .01, η2 = .17, indicating that individuals with
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higher premorbid intelligence had higher Working Memory Factor scores. No
other between-subjects effects were found to be significant, Figure 1.
Hypothesis 3b. We expected reductions in subjective cognitive symptom
complaint reporting, as measured by the Symptom Composite PC, in mTBI participants
between the sub-acute and chronic time points will be moderated by mood. We expect
demographic variables, specifically ethnicity, will account for some of the variance in
this relationship. The Repeated Measures ANCOVA from model 3.2 revealed the time by
group interaction was not significant for the Symptom Composite PC. There was no
significant difference in subjective symptom complaint reporting between the mTBI and
control group and over time.
We computed an additional Repeated Measures ANCOVA for the BDI-II at the
sub-acute time point with a Greenhouse-Geisser correction. TOPF and ethnicity were
selected as covariates and group and gender were between-subjects factors.
a. Examining within-subjects effects, a significant main effect of time, F(1,58) =
4.91, p = .03, η2 = .08, was found, indicating mTBI participants mood became
worse over time. A significant time by TOPF interaction was found, F(1,58) =
4.93, p = .03, η2 = .08. All other within-subjects interactions were not
significant.
b. Regarding between-subjects effects, there was a significant main effect of
group, F(1,58) = 12.47, p < .01, η2 = .18, indicating the mTBI group had
significantly greater (worse) mood scores than the control group at both time
points. No other between-subjects effects were found to be significant for
ethnicity (F(1,58) = .54, p = .47, η2 = .009).
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Given that there was no change over time in symptom reporting and no main
effect or interaction with ethnicity we are unable to further assess Hypothesis 3b.
DISCUSSION
This study included a secondary analysis of mTBI survivors and control
participant’s self-report of mood symptoms, subjective cognitive symptoms, and
objective neuropsychological assessment of EF deficits. The purpose of the study was to
explore and clarify the relationship among self-reported behavioral and cognitive
complaints with objectively measured EF in individuals with mTBI in the sub-acute and
chronic states of recovery. Specifically, this research attempted to explore if mood
moderated the relationship between subjective cognitive complaints and objective EF as
measured by the NIH-EXAMINER.
The data indicated at the semi-acute state of recovery, mTBI survivors reported
experiencing higher levels of mood symptoms and higher rates of mTBI symptom
sequelae. In contrast to Hypothesis 1a, mTBI participants performed as well as their noninjured counterparts on objective EF assessment. While this finding is not particularly
novel, it does provide continued evidence for higher rates of depressive symptoms
(Bombardier et al., 2010) and subjective symptom reporting (Ponsford, Cameron
Fitzgerald, Grant, & Mikocka-Walus, 2011) in mTBI patients compared with health
controls. With regard to EF scores as assessed via the NIH-EXAMINER, we did not find
significant group effects for the Executive Composite or the three factors, Fluency,
Cognitive Control, and Working Memory. Approximately two weeks post injury, mTBI
participants performed approximately the same as healthy controls on our measure of EF.
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We proposed in Hypothesis 1b that the presence of subjective cognitive symptom
complaints would negatively predict EF performance for both mTBI and control
participants. We expected that the presence of more symptoms would impact participants
ability to perform successfully on objective neuropsychological assessment measures
resulting in lower EF scores. While our Subjective Symptom PC and Executive
Composite scores at the sub-acute time point were negatively correlated, this did not
reach significance. Therefore, Hypothesis 1b was not supported. Similarly, we
hypothesized (Hypothesis 1c) that mTBI patient’s subjective reporting of symptom
severity would positive correlated with our subjective symptom measures at both the subacute and chronic time points. As expected, our analyses revealed these variables were
significantly correlated. Patients who reported experiencing more severe symptoms also
reported experiencing many symptoms. As well, we believed mTBI patient’s reporting of
more severe symptoms would correlate with neuropsychological assessment
performance. This was in fact not the case, and therefore Hypothesis 1c was also not
supported.
Following, consistent with the literature, in Hypothesis 2 we proposed that the
group differences in EF and subjective cognitive symptom complaints would be driven
by mood problems. Our results revealed EF scores did not change relative to their mood
or subjective symptom reporting. Hypothesis 2 was not supported.
Examining the impact of time on recovery from mTBI, we hypothesized mTBI
participants would improve over time in all measured domains. The literature consistently
reports improvements over time, and we proposed that participants tested at the chronic
time point would show improvements in mood, decreases in subjective reporting of
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cognitive and behavioral symptoms, and improvements in their EF scores. This
hypothesis was not supported. Overall, participants in our mTBI group experienced no
change in scores over time for any of our relevant measures. In Hypothesis 3b we
expected that in mTBI participants, reductions in subjective cognitive symptom
complaint reporting between the sub-acute and chronic time points would be moderated
by mood. Further, we expected ethnicity would account for some of the variance in this
relationship. Our analyses revealed no significant change over time for the Symptom
Composite PC. Further we found no significant effects for ethnicity.
TOPF
Though not specified in our hypotheses the Test of Premorbid Functioning
(TOPF) was employed as a covariate in our analyses and revealed interesting results.
First, mTBI participants performed significantly worse on the TOPF compared to mTBI
patients despite matching for education. Our results indicated for the mood and symptom
variables a significant time by TOPF interaction. It appears that premorbid intellectual
ability was differently related to mood and symptom reporting at the two time points. At
the sub-acute time point mTBI participants with higher premorbid intelligence reported
experiencing more mood and cognitive symptoms. In contrast, at the chronic time point,
mTBI participants with lower premorbid intelligence scores reported more mood and
cognitive symptoms. With regard to the measures of the NIH-EXAMINER, betweensubjects analyses revealed that individuals with higher premorbid intelligence received
higher EF scores and individuals with lower premorbid intelligence received lower EF
scores. This was true for the Executive Composite as well as the Cognitive Control,
Fluency, and Working Memory Factors.
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Effect Sizes
Our study revealed small effect sizes for group on the Executive Composite (d =
.14), Fluency Factor (d = .22), Cognitive Control Factor (d = .20), and Working Memory
Factor (d = .19) of the NIH-EXAMINER. While small, these effect sizes are consistent
with other reported effect sizes in the literature for EF deficits following mTBI. A metaanalysis by Schretlen and Shapiro (2003) examined effect sizes of studies reporting on
patients with mTBIs and patients with moderate to severe TBIs. Based on their review of
15 studies, the overall neuropsychological effect size (Cohen’s d) for mTBI studies of
cognitive effects was d = .24, and the effect size for moderate to severe TBIs was d = .74.
Further, examining time since injury intervals, their analyses revealed smaller effect sizes
as the time since injury increased. Injuries assessed less than seven days after the mTBI
revealed significantly higher effect sizes (d = .41), compared to injuries assessed 7-29
days post injury (d = .29), which were significantly different than assessment conducted
30-89 days post injury (d = .08). The literature supports the model that for mTBIs,
patients do not experience significant EF deficits three months post injury. And further,
EF deficits in more severely affected patients diminish as a function of time, with more
remote injuries being less problematic compared to more acute injuries. Belanger and
colleagues (2005) in their meta-analysis of mTBI patients report similar small effect sizes
for the EF domain (d = .21) within the first three months and no significant effect sizes
after 90 days.
For individuals who sustain a mTBI, meta-analyses typically report overall mild
neuropsychological impairment across domains within the first 90 days post injury. The
largest effects of cognitive deficits are usually found in the domains of fluency and
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delayed memory in the acute period. At three months follow up, these effects often fall to
essentially zero (Belanger, Curtiss, Demery, Leibowitz, & Vanderploeg, 2005; Schretlen
and Shapiro, 2003). Another recent meta-analysis (Karr, Areshenkoff, & Garcia-Barrera,
2014) examined neuropsychological outcomes of mTBI and found staggering variability
in effect sizes for cognitive domains, including EF. It is important to note that studies and
meta-analyses are often inconsistent in operationally defining each neuropsychological
domain. For example, the meta-analysis by Belanger and colleagues (2005) defined
fluency to encompass both verbal and nonverbal fluency whereas we assessed only verbal
fluency. Additionally, Belanger & Vanderploeg (2005) included fluency tasks as EF
measures and yet Belanger, Curtiss, Demery, Lebowitz, and Vanderploeg (2005) defined
fluency as a separate construct.
Consistent with the literature, we would expect to see larger deficits in EF acutely
with the expectation patients would recover and EF deficits would dissipate over time.
Our study not only found small effect sizes for EF deficits in the mTBI population, our
analyses also revealed mTBI and control participants did not differ significantly in EF
performance, at least with the power available in this study. mTBI patients performed just
as well as control participants on our measure of EF, the NIH-EXAMINER. Furthermore,
mTBI patients showed no significant improvement in EF functioning between two weeks
post injury and two months post injury. On objective EF testing mTBI patients showed
no significant deficits compared with healthy controls. And yet, mTBI patients
subjectively report experiencing cognitive changes including EF deficits that impact their
ability to function successfully in daily life. Executive functions comprise higher-order
cognitive abilities such as cognitive flexibility, problem solving, concept formation, self-
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regulation, working memory, and attention (Raymar, Roitsch, Redman, Michalek, &
Johnson, 2018). These skills are essential for goal-directed behavior and for responding
to novel stimuli in an individual’s environment. Reported subjective deficits in EF are
among the enduring cognitive problems reported following a mTBI. These difficulties,
whether perceived or objectively assessed in testing, can interfere with an individual’s
ability to complete instrumental activities of daily living as well as actively participate in
cognitive and physical rehabilitation (Raymar et al., 2018). mTBI is often characterized
by subjective complaints of cognitive impairment in the absence of objective
neuropsychological findings that persist past the first few weeks post injury (Karr et al.,
2014). mTBI survivors frequently report impairments in concentration, memory, and
attention, although objective neuropsychological assessment beyond the first couple of
weeks indicates performance in the normal range. These cognitive symptoms are
generally transient for most individuals but persist in a small subset (Karr et al. 2014). In
contrast, patients with moderate and severe TBIs may lack insight and be unaware of
their cognitive deficits. On objective assessment they usually show impaired performance
in one or more cognitive testing domain (Eshel, Bowels & Ray, 2019).
The Construct of EF
In interpreting the preceding results, it is necessary to consider the question, do
performance-based measures and self-report ratings of EF assess the same construct? In
this study, one performance-based measure (NIH-EXAMINER) and several rating
measures were used (FrSBe, NSI, PROMIS) in an attempt to assess EF performance both
objectively and subjectively. While this was one way to evaluate study participant’s EF
skills, we must turn to the literature to review the best way to operationalize and measure
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EF. Performance-based measures involve the use of highly standardized procedures that
are administered by an examiner to an examinee and the measures typically assess the
accuracy and/or response time. The stimulus presentation is precisely controlled so each
examinee completes the task in the same way as all other examinees (Toplak, West, &
Stanovich, 2013). In contrast, rating scales and measures of EF involve either the
individual or an informant reporting on perceived difficulties. Importantly, a central
supposition underlying EF rating measures is that they are measuring behaviors that are
related to the processes that performance-based measures are assessing. Therefore, if
performance-based measures and rating measures of EF are measuring the same
construct, then these measures should be strongly positively correlated. A recent metaanalysis by Toplak, West, and Stanovich (2013) examined 20 studies in the child
literature to address this question. Overall, they found 24% of the correlational
comparisons between performance-based measures and rating measures of EF were
statistically significant and of those, the magnitude of the correlations were typically low.
Across all studies, the median correlation was .19. The authors note that if both types of
measures were measuring the same construct, then convergent validity should be present.
A basic principle of convergent validity is that the operational measures of the same
construct should be highly correlated, this is not the case in this study (Toplak, West, &
Stanovich, 2013). While both types of assessment are valuable, it cannot be assumed that
they are measuring the same construct and should not be used interchangeably.
Therefore, it appears these measures are more related to mood than objectively assessed
EF cognition.
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NIH-EXAMINER Limitations
As previously reported, our study revealed significant differences between mTBI
and control participants at the sub-acute time point for mood and subjective symptom
reporting but not for the Executive Composite or the Fluency, Cognitive Control, and
Working Memory factors of the NIH-EXAMINER. Another possible explanation for the
lack of difference between mTBI and healthy control participants scores on EF measures
is the test itself.
In an effort to make the NIH-EXAMINER tasks shorter and easier to administer
to larger populations, one could argue that the authors compromised the integrity of the
individual measures. One such example of this is the continuous performance task (CPT)
subtest used in the NIH-EXAMINER. This measure aims to assess a participants
sustained and selective attention and is typically used in assisting in the diagnosis of
ADHD. Since the first version of the CPT was developed (Rosvold et al., 1956), the test
has been modified several times and two of the most commonly used versions of the CPT
are the Integrated the Test of Variables of Attention (T.O.V.A.) (Greenberg & Waldmant,
1993) and the Conners’ CPT-II (Conners, 2000). The T.O.V.A is approximately 21.6
minutes long for adults (Greenberg & Waldmant, 1993) and the CPT-II has a duration of
14 minutes and is made up of six blocks that are split into three sub blocks (Homack &
Riccio, 2006). In contrast, the NIH-EXAMINER CPT consists of 100 trials that are
divided into four blocks of 25 trials but does not provide the overall task duration for the
CPT (Kramer, 2001). Furthermore, on the website, the authors assert the CPT used on the
NIH-EXAMINER is not the Conners’ CPT-II. Instead the authors state that CPT is a
custom task they designed specifically for this battery and it is based on pilot testing, but
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they do not provide information on the pilot study or norms for this new CPT version
(EXAMINER FAQ, 2019). This pattern of shortening sub-test measures is seen in several
additional parts of the NIH-EXAMINER. Specifically, the dot-counting, flanker task, and
set-shifting task have been shortened. Per the manual, to reduce time of administration
and patient burden the trials of the dot counting task were reduced by half, from twelve
trials to six trials. The flanker task trials were reduced from 64 to 48 and the set shifting
subtest trials were reduced from 120 to 104 (Kramer, 2001). This might affect reliability
less than validity, if TBI deficits are somewhat episodic
One of the core features or strengths of the CPT is the long duration an examinee
has to sustain attention. This results in increased fatigue, assessment of distress tolerance,
less opportunities for loss of concentration if they have attentional difficulties. One could
argue that shortening the CPT may result in the test not measuring the construct it is
intending to measure.
In the NIH-EXAMINER, the Fluency Factor is made up of phonemic and
category fluency. These measures appear to be, for the most part, unchanged from
traditional neuropsychological measures of verbal fluency including the Controlled Oral
Word Association Test (COWAT) (Benton, Hamsher, & Sivan, 1994) and the F-A-S Test
(Spreen & Benton, 1997). In the standard versions of the tasks, the examinee is given one
minute to produce as many unique words as possible starting with a given letter (letter
fluency) or within a semantic category (category fluency). The participant's score in each
task is the number of unique correct words. Verbal fluency tasks are often conceptualized
and used in research and clinical practice as a measure of EF. However, research has
begun to consider the language component in these tasks. Successful performance on the
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verbal fluency task has been cited in some studies as a complex interplay of both EF and
language (Unsworth, Spillers, & Brewer, 2011). Whiteside and colleagues (2015)
examined the underlying cognitive structure of verbal fluency using EF and language
measures via exploratory factor analyses. Their results indicated a two-factor structure of
language and EF. Surprisingly, FAS and Animal fluency loaded exclusively on the
language factor (Whiteside et al., 2015). In our study, the Fluency Factor was revealed to
not significantly differ between healthy controls and mTBI patients two weeks post injury
one explanation for this is that we only tested verbal fluency and did not include
measures of non-verbal fluency. It may be that acutely following a mTBI non-verbal
fluency is impacted while verbal fluency is not. The effect size estimate from our verbal
fluency measure was d = .22. while Belanger and colleagues meta-analysis (2005)
fluency measure (verbal and non-verbal) had an effect size of d = .89.
While the authors provide plausible justification for their decision to remove trials
in the manual (Kramer, 2001), this raises the question of norms as each altered sub test
requires new norms to validate their claims. If the shortened versions of the test were
substantially validated with normative data, the test designers would have stronger
support of the validity of the NIH-EXAMINER. Thus, it is possible that the NIHEXAMINER slightly underestimated the true extent of any cognitive deficit.
Normative Data
In neuropsychological testing, the conventional method used to identify abnormal
cognitive performance is by comparing an individual’s cognitive performance with that
of a reference or normative group studied at a single time point (Kendall, Marrs-Garcia,
Nath, & Sheldrick, 1999). The normative data often takes into account variables such as
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an individual’s age, gender, ethnicity, and level of education (Merritt et al., 2016).
Normative data helps clinicians and researchers place the individual into a sociocultural
context. A patient may feel they performed poorly on a task but upon comparison to the
normative data sample the patient may instead present in the average range. The reverse
scenario is also possible. Normative data is vital is assessing cognitive performance
declines by placing performance into a context for accurate interpretation. The website
for the NIH-EXAMINER specifies they lack normative data for individual subtest or
composite scores for their assessment battery. The test designers acknowledge this is
problematic and hope to assemble age or age and education based normative data, but as
of this time this has not been done. Of note, they do offer the option for providers to
contact them via email to have access to their data same of 600 controls organized by age
(EXAMINER FAQ, 2019). While this is a nice gesture it is nonetheless problematic for
clinicians. Not having normative data is not an issue for research studies with a health
control group but it does pose problems for clinical applications. It is preferable to have
an assessment test that can be used in both in a clinical and research setting.
A second essential component of normative data in neuropsychological
assessment is relevant norms based on patient population (Merritt et al., 2016).
Normative data at a minimum usually includes age and gender but unfortunately it often
lacks satisfactory race and ethnicity norms. These norms are useful for assessment in the
general population but sub samples of patient groups that more closely resemble the
characteristics and demographics of the patient population in question are significantly
more valuable (Merritt et al., 2016). The NIH-EXAMINER manual specifies the battery
was tested on sample of 19 people aged 18 to 50 years, who sustained a TBI ranging in
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severity from moderate to severe. All participants in this group had sustained their injury
at least 6-months prior to testing (Kramer, 2001). This patient population stands in stark
contrast to the participants in this study who all sustained mTBIs and were tested with
this battery within two weeks of their injury.
The NIH-EXAMINER not only lacks patient population specific norms it also
lacks even the most basic age, gender, race, ethnicity, and years of education normative
data. This is again problematic for the clinical use of this instrument. A review of the
literature indicates that researchers have been utilizing this measure across several
medical and mental health populations to test its reliability and validity (Krueger et al.,
2009; You et al., 2013; Possin, LaMarre, Wood, Mungas, & Kramer, 2014). Our study
utilized a sample of 52 mTBI patients and found small effect size estimates that are
comparable to the small EF effect sizes reported in the literature for mTBI patients.
Taken together, it appears the NIH-EXAMINER may be an adequate measure of
EF even though the effect sizes are small. A possible explanation of this result is that
mTBI patients are actually not experiencing EF deficits. mTBI patients, in contrast to
those who sustain moderate or severe TBIs, on objective testing do not appear to have EF
deficits. It may be that there is something inherent in the mTBI population wherein they
report subjective cognitive complaints despite not evidence of objective impairment. This
finding has implications for treatment.
Treatment
Overall, results of our study revealed mTBI patients experienced large effects for
depressed mood and only small effects for EF impairments. We propose one of the most
important and often overlooked components in the treatment of patients with mTBI is in
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treating the functional impact these impairments have on the individual. Our study found
no change over time for negative mood complaints and subjective symptom reporting of
cognitive complaints. Patients in our study were just as depressed at the chronic time and
had the same cognitive complaints as they did two-week post injury. This finding, which
falls contrary to expected mTBI recovery trajectories, is particularly troubling and has
implications for treatment.
As stated previously, while most individuals who sustain a mTBI typically
recover completely within the a few weeks or months of their injury, a significant
minority continue to experience persistent negative symptoms months to years later
(Vanderploeg, Curtiss, Luis, & Salazar, 2007). This begs the question of what treatment
is best suited for this population and when is the best time to administer intervention for
best outcomes. One avenue for intervention that has been investigated is the question of
whether psychoeducation and supportive interventions in the acute phase can prevent the
progression of symptoms to persistent PCS. These interventions are based on the theory
that persistent PCS are related to the misattribution of symptoms to the mTBI and the
patient’s negative expectations about recovery (Belanger, Barwick, Kip, Kretzmer, &
Vanderploeg, 2013). Given that negative perceptions of mTBI are one of the best
predictors of PCS at six months post-injury, this is an ideal treatment target (Hou et al.,
2012).
Psychoeducation and supportive interventions typically involve education on
post-concussive symptoms, guidance on rest and gradual reintegration of typical
activities, education on coping strategies, and reassurance on the expectation of a
complete recovery (Prince and Bruhns, 2017). Of all post-mTBI interventions,
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psychoeducational and supportive interventions have the strongest empirical evidence
(Comper, Bisschop, Carnide, & Tricco, 2005). Even simple education and support about
mTBI symptom sequelae and expected recovery provided shortly after injury has been
shown to results in a reduction in somatic and psychological complaints (Comper et al.,
2005). Furthermore, a single session early intervention can prevent PCS as effectively as
traditional outpatient therapy (Mittenberg, Canyock, Condit, & Patton, 2001).
Treatment of cognitive dysfunction following mTBI should be functionally
oriented and should relate directly to the real-life context the individual exists within as
much as possible. The two types of treatment for cognitive dysfunction are normally
characterized as compensatory or restorative. A compensatory approach tries to provide
internal mental strategies such as mnemonics or external aides such as notebooks to help
with patient’s daily activities despite the presence of a cognitive impairment. On the other
hand, restorative approaches attempt to improve the overall performance of a cognitive
system with the ultimate goal of improving performance of actives that depend on the
functioning of a particular system (Eshel, Bowels, & Ray, 2018). A particular strength of
mTBI patients in comparison to patients with moderate or severe TBIs is they typically
have greater insight which may result in a better understanding of the injury and
treatment process.
Another avenue of treatment for persistent post-concussion symptoms following a
mTBI is the treatment of depression or depressive symptoms using empirically supported
therapies. Our study results revealed that mTBI patients experienced more symptoms of
depression than healthy controls and more symptoms two weeks post injury and 2 months
post injury. While rates of depression in the general population range from 8-11%
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(Guillamondegui et al., 2011), rates of depression in mTBI patients range from 10-77%
(Silver, McAllister, & Arciniegas, 2009). Depression appears to be a clear treatment
target. Looking at the depression literature, perceived cognitive impairment is a hallmark
symptom of depression (Channon & Green, 1999; Zakzains, Leach & Kaplan, 1998).
Treatment of depression following mTBI may alleviate other post-concussive symptoms
such as cognitive impairment in addition to improving mood (Silver, McAllister, &
Arciniegas, 2009). In our study effect size estimates for depressed mood were many
times larger (d = .90) than effect size estimates of EF impairments (d = .14), thus making
depression a prime treatment target.
Limitations
There were several major limitations to this current study. First, we experienced
practical difficulties in participant attendance and attrition. While mTBI patients were
approached immediately post injury they varied in the time between when they sustained
the injury and when they completed the first session. The majority of patients, 84.5% did
not attend the first study session until between 11- and 14-days post injury. There is the
possibility that patients assessed more closely to the injury date would have shown
change over time in self-reported mood and symptoms and possibly significant
differences in EF performance. Given the small sample size of participants who came in
between one- and seven-days post injury, we were unable to assess if these participants
experienced a change in scores over time compared to more remotely assessed patients.
One could hypothesize that the population of mTBI patients who participated in the study
at the first and second time points were a subset of the least impaired individuals who had
sustained an mTBI. These individuals presumably had access to transportation and were
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functioning (i.e., in terms of pain complaints) well enough post-injury to participate in
our study.
Another possible limitation with this study is participant employment status.
While more mTBI patients than control patients were unemployed at the time of the first
assessment, a large proportion 18.7% of control participants were unemployed (looking
for work, temporarily laid off, or disabled) at the time of the first assessment. Per the
literature, for those who are employed preinjury, unemployment rates at one-year postinjury have been found to be 31% among persons with mTBI (Doctor et al., 2005). The
cognitive and behavioral sequelae that occur following a mTBI can interfere with
returning to or gaining employment even in patients who were employed prior to their
injury. Employment is an important measure of social functioning that has been shown to
positively influence a variety of areas in an individual’s life including: less health service
usage, findings of better health status in people who are employed, a better sense of
wellbeing, greater social integration within the community, more social contacts, and a
better QOL than people who are not employed (van Velzen, van Bennekom, Edelaar,
Sluiter, & Frings-Dresen, 2009). The high rate of healthy control participants who were
unemployed at the time of the first session may have been a factor in mood and symptom
reporting, resulting in higher than expected control scores.
An additional limitation is our examination of socio-economic status (SES).
Given the complexity in selecting variables for SES we choose to use the dichotomized
variable of ethnicity, and the TOPF as a measure of SES as the TOPF correlated strongly
with education. In this study the mTBI and control groups did not differ significantly in
terms of sex, age, race, ethnicity, years of education, and marital status. We did not
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examine additional SES variables in our analyses which is a limitation to this study. Due
to small sample sizes for our race and other potential SES variables, we were unable to
fully examine the role of race and other SES factors on mood, subjective symptom
reporting, and EF. While the participants in this study were all from the Albuquerque,
New Mexico area, this study could benefit from neighborhood analysis to assess if some
of the variance in our results could be accounted for by what neighborhood an individual
grew up in.
The self-report and performance-based measures utilized in our study also present
several limitations. Measures of mood were limited to one measure, the BDI-II. The BDIII, while well validated in the literature (Segal, Coolidge, Cahill, & O’Riley, 2008) was
not expressly designed to assess depression symptomatology in a TBI or mTBI
population. As well, our measure of mood was actually a more specific measure of
depression. The term mood encompasses several symptom presentations not just
depression. For example, this study could have benefited from employing multiple
measures of mood including measures of anxiety. mTBI patients typically report
experiencing significant anxiety symptoms following a mTBI compared to healthy
controls (Wood, O’Hagan, Williams, McCabe, & Chadwick, 2014). Multiple mood
measures would have allowed for more in-depth analyses of the post-concussion
symptom profile.
Our measure of subjective cognitive symptom reporting was developed using a
principal components analysis of the variables that were available in this secondary
analysis. While the principal component accounted for over 75% of the variance of
symptom measures it also correlated highly with the BDI-II. A review of the NSI and
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FrSBe items indicated significant overlap of mood question with the BDI-II. Given the
limitations of the measures used for symptom reporting we were unable to clearly
separate a pure mood and pure symptom variable.
The performance-based EF measure had several limitations. The central
neuropsychological assessment measure utilized in this study, the NIH-EXAMINER
assessment battery, was the only means of assessing EF. As previously discussed, this
battery, had several potential drawbacks. First, the NIH-EXAMINER is a relatively new
assessment battery that has not be adequately normed for clinical use with TBI or mTBI
populations. This is not an issue for our research study that contained healthy controls but
does pose limitations for clinical implications. Further, several sub-tests of the measure
were shortened by the test designers with the aim of reducing time and test taking burden.
Unfortunately, these changes, namely removing several trials and reducing the test taking
time of the CPT by over half, may have altered the sub-tests and as a result could explain
why our effect size for the Fluency Factor differed from literature reports.
Summary, Clinical Implications, and Conclusions
Although the main aim of the study, which was to determine if mood moderated
the relationship between subjective cognitive complaints and objective EF deficits, was
not supported by the current data, other valuable, preliminary findings arose that have
important clinical implications. Our results revealed abundant evidence of mood
dysfunction following mTBI that did not dissipate over time as the literature would
suggest. We argue that research into the evaluation and treatment of post-concussion
symptoms has focused almost exclusively on cognitive impairments at the expense of
investigating mood problems. Clinical psychologists are well versed in a plethora of
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empirically supported therapies for mood dysfunction, including Acceptance and
Commitment Therapy for Depression, Behavioral Activation for Depression, and
Cognitive Therapy for Depression. Psychologists have at their disposal several well
validated treatments that may be directly applicable in the treatment of patients with postconcussion symptoms. Further our study revealed a small effect size for EF deficits (d =
.14) that would not preclude the necessary EF skills to participate effectively in
psychotherapy intervention.
A person’s perception of reality is in turn their own reality. It is essential that
mental health practitioners take patient’s subjective reporting of symptoms seriously.
These complaints should be respected comparable to clinician’s perceptions of objective
neuropsychological assessment. Even though performance-based and self-report
assessments may measure different constructs of EF, dismissing these complaints is not
only harmful to the patient, it also dismisses vital information that can have implications
for rehabilitation. For example, a mTBI participant may report poor mood, fatigue, and
apathy. One could propose that these symptoms may directly impact their ability to
effectively participate in rehabilitation and further may be a barrier to care. Treatment of
mood symptoms may increase patient engagement in vital rehabilitation services.
Psychologists have a vital role to play in the treatment of post-concussion symptoms.
In conclusion, this study improves our understanding of the relationship between
mood symptoms, subjective cognitive symptom complaints, and objective assessment of
EF deficits. Focusing exclusively on subjective and objective cognitive deficits at the
expense of mood deficits does a disservice to our patients. Psychologist have a unique
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opportunity to be at the forefront of mTBI mood treatment to improve quality of life in a
significant population of patients who continue to suffer with post-concussion symptoms.

REFERENCES
American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental
Disorders 5th Edn. Arlington, VA: American Psychiatric Publishing;
10.1176/appi.books.9780890425596
Arango-Lasprilla, J. C., Ketchum, J. M., Williams, K., Kreutzer, J. S., Marquez de la
Plata, C. D., O’Neil-Pirozzi, T. M., & Wehman, P. (2008). Racial Differences in
Employment Outcomes After Traumatic Brain Injury. Archives of Physical
66

Medicine and Rehabilitation, 89(5), 988–995.
https://doi.org/10.1016/j.apmr.2008.02.012
Arango-Lasprilla, J. C., Rosenthal, M., DeLuca, J., Cifu, D. X., Hanks, R., & Komaroff,
E. (2007). Functional Outcomes From Inpatient Rehabilitation After Traumatic
Brain Injury: How Do Hispanics Fare? Archives of Physical Medicine and
Rehabilitation, 88(1), 11–18. https://doi.org/10.1016/j.apmr.2006.10.029
Arciniegas, D. B., Held, K., & Wagner, P. (2002). Cognitive Impairment Following
Traumatic Brain Injury. Current Treatment Options in Neurology, 4(1), 43–57.
Bay E, Donders J. Risk factors for depressive symptoms after mild-to-moderate traumatic
brain injury. Brain Injury. 2008; 22:233–241. [PubMed: 18297595]
Beck, A.T., Steer, R.A., & Brown, G.K. (1996). Manual for the Beck Depression
Inventory-II. San Antonio, TX: Psychological Corporation.
Belanger, H. G., Barwick, F. H., Kip, K. E., Kretzmer, T., & Vanderploeg, R. D. (2013).
Postconcussive Symptom Complaints and Potentially Malleable Positive
Predictors. The Clinical Neuropsychologist, 27(3), 343–355.
https://doi.org/10.1080/13854046.2013.774438
Belanger, H. G., Curtiss, G., Demery, J. A., Lebowitz, B. K., & Vanderploeg, R. D.
(2005). Factors moderating neuropsychological outcomes following mild
traumatic brain injury: a meta-analysis. Journal of the International
Neuropsychological Society: JINS, 11(3), 215–227.
https://doi.org/10.1017/S1355617705050277

67

Belanger, H. G., & Vanderploeg, R. D. (2005). The neuropsychological impact of sportsrelated concussion: A meta-analysis. Journal of the International
Neuropsychological Society, 11, 345–357.
Benton, A. L., Hamsher, K. de S., & Sivan, A. B. (1994). Multilingual Aphasia
Examination-Third Edition. Iowa City, IA: AJA Associates.
Boake, C., McCauley, S. R., Levin, H. S., Pedroza, C., Contant, C. F., Song, J. X., …
Diaz-Marchan, P. J. (2005). Diagnostic criteria for postconcussional syndrome
after mild to moderate traumatic brain injury. The Journal of Neuropsychiatry and
Clinical Neurosciences, 17(3), 350–356. https://doi.org/10.1176/jnp.17.3.350
Bombardier, C. H., Fann, J. R., Temkin, N. R., Esselman, P. C., Barber, J., & Dikmen, S.
S. (2010). Rates of major depressive disorder and clinical outcomes following
traumatic brain injury. JAMA, 303(19), 1938–1945.
https://doi.org/10.1001/jama.2010.599
Carroll, L. J., Cassidy, J. D., Peloso, P. M., Borg, J., von Holst, H., Holm, L., … WHO
Collaborating Centre Task Force on Mild Traumatic Brain Injury. (2004).
Prognosis for mild traumatic brain injury: results of the WHO Collaborating
Centre Task Force on Mild Traumatic Brain Injury. Journal of Rehabilitation
Medicine, (43 Suppl), 84–105.
Centers for Disease Control and Prevention (CDC), 2014 Report to Congress Traumatic
Brain Injury In the United States: Epidemiology and Rehabilitation . Centers for
Disease Control and Prevention, National Center for Injury Prevention and
Control.

68

Chamelian L, Feinstein A. The effect of major depression on subjective and objective
cognitive deficits in mild to moderate traumatic brain injury. Journal of
Neuropsychiatry and Clinical Neurosciences. 2006; 18(1):33–38. [PubMed:
16525068]
Channon, S., & Green, P. (1999). Executive function in depression: the role of
performance strategies in aiding depressed and non-depressed participants.
Journal of Neurology, Neurosurgery, and Psychiatry, 66(2), 162–171.
Cicerone KD, Kalmar K. Persistent postconcussion syndrome: the structure of subjective
complaints after mTBI. J Head Trauma Rehabil. 1995;10:1–17.
Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.).
Hillsdale, NJ: Lawrence Earlbaum Associates.
Comper, P., Bisschop, S. M., Carnide, N., & Tricco, A. (2005). A systematic review of
treatments for mild traumatic brain injury. Brain Injury, 19(11), 863–880.
https://doi.org/10.1080/02699050400025042
Conners, C. K. (2000). Conners’Continuous Performance Test user’s manual. Toronto,
Canada: Multi-Health Systems.
Deb, S., Lyons, I., Koutzoukis, C., Ali, I., & McCarthy, G. (1999). Rate of psychiatric
illness 1 year after traumatic brain injury. The American Journal of Psychiatry,
156(3), 374–378. https://doi.org/10.1176/ajp.156.3.374
Denning, J. H. (2012). The Efficiency and Accuracy of The Test of Memory Malingering
Trial 1, Errors on the First 10 Items of The Test of Memory Malingering, and
Five Embedded Measures in Predicting Invalid Test Performance. Archives of
Clinical Neuropsychology, 27(4), 417–432. https://doi.org/10.1093/arclin/acs044

69

Denning, J. H., & Shura, R. D. (2017). Cost of malingering mild traumatic brain injuryrelated cognitive deficits during compensation and pension evaluations in the
veterans benefits administration. Applied Neuropsychology: Adult, 0(0), 1–16.
https://doi.org/10.1080/23279095.2017.1350684
Dikmen, S., Machamer, J., Fann, J. R., & Temkin, N. R. (2010). Rates of symptom
reporting following traumatic brain injury. Journal of the International
Neuropsychological Society, 16, 401–411.
Dikmen, S., Machamer, J., Miller, B., Doctor, J., & Temkin, N. (2001). Functional status
examination: a new instrument for assessing outcome in traumatic brain injury.
Journal of Neurotrauma, 18(2), 127–140.
https://doi.org/10.1089/08977150150502578
Doctor, J. N., Castro, J., Temkin, N. R., Fraser, R. T., Machamer, J. E., & Dikmen, S. S.
(2005). Workers’ risk of unemployment after traumatic brain injury: a normed
comparison. Journal of the International Neuropsychological Society: JINS,
11(6), 747–752. https://doi.org/10.1017/S1355617705050836
Edna, T. H., & Cappelen, J. (1987). Return to work and social adjustment after traumatic
head injury. Acta Neurochirurgica, 85(1–2), 40–43.
Eshel, I., Bowles, A. O., & Ray, M. R. (2019). Rehabilitation of Cognitive Dysfunction
Following Traumatic Brain Injury. Physical Medicine and Rehabilitation Clinics
of North America, 30(1), 189–206. https://doi.org/10.1016/j.pmr.2018.08.005
EXAMINER FAQ. (2019) Retrieved from https://memory.ucsf.edu/examiner-faq
Eyres, S., Carey, A., Gilworth, G., Neumann, V., & Tennant, A. (2005). Construct
validity and reliability of the Rivermead Post-Concussion Symptoms

70

Questionnaire. Clinical Rehabilitation, 19(8), 878–887.
https://doi.org/10.1191/0269215505cr905oa
Faul, M., & Coronado, V. (2015). Epidemiology of traumatic brain injury. Handbook of
Clinical Neurology, 127, 3–13. https://doi.org/10.1016/B978-0-444-528926.00001-5
Faul M, Xu L, Wald MM, Coronado VG. (2010). Traumatic Brain Injury in the United
States: Emergency Department Visits, Hospitalizations and Deaths 2002–
2006.Atlanta (GA): Centers for Disease Control and Prevention, National Center
for Injury Prevention and Control.
Frencham, K. A. R., Fox, A. M., & Maybery, M. T. (2005). Neuropsychological studies
of mild traumatic brain injury: a meta-analytic review of research since 1995.
Journal of Clinical and Experimental Neuropsychology, 27(3), 334–351.
https://doi.org/10.1080/13803390490520328
Friedland, D.P. (2013). Improving the Classification of Traumatic Brain Injury: The
Mayo Classification System for Traumatic Brain Injury Severity. J Spine S4:005.
doi:10.4172/2165-7939.S4-005
Gaines, K. D., Soper, H. V., & Berenji, G. R. (2016). Executive Functioning of Combat
Mild Traumatic Brain Injury. Applied Neuropsychology. Adult, 23(2), 115–124.
https://doi.org/10.1080/23279095.2015.1012762
Gardner, R. C., Langa, K. M., & Yaffe, K. (2017). Subjective and objective cognitive
function among older adults with a history of traumatic brain injury: A
population-based cohort study. PLoS Medicine, 14(3).
https://doi.org/10.1371/journal.pmed.1002246

71

Grace, J., & Malloy, P. (2001). The Frontal Systems Behavior Scale manual. Odessa, FL:
Psychological Assessment Resources.
Greenberg, L. M., & Waldmant, I. D. (1993). Developmental Normative Data on The
Test of Variables of Attention (T.O.V.A.TM). Journal of Child Psychology and
Psychiatry, 34(6), 1019–1030. https://doi.org/10.1111/j.14697610.1993.tb01105.x
Guillamondegui O. D., Montgomery S. A., Phibbs F. T., McPheeters M. L., Alexander P.
T., Jerome R. N., et al. (2011). Traumatic Brain Injury and
Depression. Rockville, MD: Agency for Healthcare Research and Quality (US)
Guise, E. de, Bélanger, S., Tinawi, S., Anderson, K., LeBlanc, J., Lamoureux, J., …
Feyz, M. (2016). Usefulness of the rivermead postconcussion symptoms
questionnaire and the trail-making test for outcome prediction in patients with
mild traumatic brain injury. Applied Neuropsychology: Adult, 23(3), 213–222.
Hays, R. D., Spritzer, K. L., Schalet, B. D., & Cella, D. (2018). PROMIS®-29 v2.0
profile physical and mental health summary scores. Quality of Life Research,
27(7), 1885–1891. https://doi.org/10.1007/s11136-018-1842-3
Homack, S., & Riccio, C. A. (2006). Conners’ Continuous Performance Test (2nd ed.;
CCPT-II). Journal of Attention Disorders, 9(3), 556–558.
https://doi.org/10.1177/1087054705283578
Hou, R., Moss-Morris, R., Peveler, R., Mogg, K., Bradley, B. P., & Belli, A. (2012).
When a minor head injury results in enduring symptoms: A prospective
investigation of risk factors for postconcussional syndrome after mild traumatic
brain injury. Journal of Neurology, Neurosurgery and Psychiatry, 83, 217–223.

72

Imbach, L. L., Büchele, F., Valko, P. O., Li, T., Maric, A., Stover, J. F., … Baumann, C.
R. (2016). Sleep-wake disorders persist 18 months after traumatic brain injury but
remain underrecognized. Neurology, 86(21), 1945–1949.
https://doi.org/10.1212/WNL.0000000000002697
Jorge, R. E., Robinson, R. G., Moser, D., Tateno, A., Crespo-Facorro, B., & Arndt, S.
(2004). Major Depression Following Traumatic Brain Injury. Archives of General
Psychiatry, 61(1), 42–50. https://doi.org/10.1001/archpsyc.61.1.42
Jurick, S. M., Crocker, L. D., Sanderson-Cimino, M., Keller, A. V., Trenova, L. S., Boyd,
B. L., … Jak, A. J. (2018). Contributions to Executive Dysfunction in Operation
Enduring Freedom/Operation Iraqi Freedom Veterans With Posttraumatic Stress
Disorder and History of Mild Traumatic Brain Injury. The Journal of Head
Trauma Rehabilitation, 33(2), E41–E52.
https://doi.org/10.1097/HTR.0000000000000313
Karr, J. E., Areshenkoff, C. N., & Garcia-Barrera, M. A. (2014). The neuropsychological
outcomes of concussion: a systematic review of meta-analyses on the cognitive
sequelae of mild traumatic brain injury. Neuropsychology, 28(3), 321–336.
https://doi.org/10.1037/neu0000037
Karzmark, P., Hall, K., & Englander, J. (1995). Late-onset post-concussion symptoms
after mild brain injury: the role of premorbid, injury-related, environmental, and
personality factors. Brain Injury, 9(1), 21–26.
Kaup, A. R., Peltz, C., Kenney, K., Kramer, J. H., Diaz-Arrastia, R., & Yaffe, K. (2017).
Neuropsychological Profile of Lifetime Traumatic Brain Injury in Older Veterans.

73

Journal of the International Neuropsychological Society: JINS, 23(1), 56–64.
https://doi.org/10.1017/S1355617716000849
Kendall, P. C., Marrs-Garcia, A., Nath, S. R., & Sheldrick, R. C. (1999). Normative
comparisons for the evaluation of clinical significance. Journal of Consulting and
Clinical Psychology, 67(3), 285–299. https://doi.org/10.1037/0022-006X.67.3.285
King, N. S., Crawford, S., Wenden, F. J., Moss, N. E. G., & Wade, D. T. (1995). The
Rivermead Post Concussion Symptoms Questionnaire: a measure of symptoms
commonly experienced after head injury and its reliability. Journal of Neurology,
242(9), 587–592. https://doi.org/10.1007/BF00868811
King, P. R., Donnelly, K. T., Donnelly, J. P., Dunnam, M., Warner, G., Kittleson, C. J.,
… Meier, S. T. (2012). Psychometric study of the Neurobehavioral Symptom
Inventory. Journal of Rehabilitation Research and Development, 49(6), 879–888.
Kramer, J. (2011). Executive Abilities: Measures and Instruments for Neurobehavioral
Evaluation and Research (EXAMINER). Retrieved
from http://examiner.ucsf.edu/EXAMINER%20User%20Manual.pdf
Kramer, J. H., Mungas, D., Possin, K. L., Rankin, K. P., Boxer, A. L., Rosen, H. J., …
Widmeyer, M. (2014). NIH EXAMINER: Conceptualization and Development of
an Executive Function Battery. Journal of the International Neuropsychological
Society, 20(1), 11–19. https://doi.org/10.1017/S1355617713001094
Krueger, C.E., Bird, A.C., Growdon, M.E., Jang, J.Y, Miller, B.L., Kramer, J.H. (2009).
Conflict monitoring in early frontotemporal dementia. Neurology, 73(5). 349-55.
doi: 10.1212/WNL.0b013e3181b04b24

74

Lange, R. T., Iverson, G. L., & Rose, A. (2010). Post-concussion Symptom Reporting
and the “Good-Old-Days” Bias Following Mild Traumatic Brain Injury. Archives
of Clinical Neuropsychology, 25(5), 442–450.
https://doi.org/10.1093/arclin/acq031
Levin, H. S., & Diaz-Arrastia, R. R. (2015). Diagnosis, prognosis, and clinical
management of mild traumatic brain injury. The Lancet. Neurology, 14(5), 506–
517. https://doi.org/10.1016/S1474-4422(15)00002-2
Ma, V. Y., Chan, L., & Carruthers, K. J. (2014). Incidence, Prevalence, Costs, and Impact
on Disability of Common Conditions Requiring Rehabilitation in the United
States: Stroke, Spinal Cord Injury, Traumatic Brain Injury, Multiple Sclerosis,
Osteoarthritis, Rheumatoid Arthritis, Limb Loss, and Back Pain. Archives of
Physical Medicine and Rehabilitation, 95(5), 986–995.e1.
https://doi.org/10.1016/j.apmr.2013.10.032
Malloy, P., & Grace, J. (2005). A review of rating scales for measuring behavior change
due to frontal systems damage. Cognitive and Behavioral Neurology: Official
Journal of the Society for Behavioral and Cognitive Neurology, 18(1), 18–27.
Mantua, J., Henry, O. S., Garskovas, N. F., & Spencer, R. M. C. (2017). Mild Traumatic
Brain Injury Chronically Impairs Sleep- and Wake-Dependent Emotional
Processing. Sleep, 40(6). https://doi.org/10.1093/sleep/zsx062
Merritt, V. C., Meyer, J. E., Cadden, M. H., Roman, C. A. F., Ukueberuwa, D. M.,
Shapiro, M. D., & Arnett, P. A. (2017). Normative Data for a Comprehensive
Neuropsychological Test Battery used in the Assessment of Sports-Related

75

Concussion. Archives of Clinical Neuropsychology, 32(2), 168–183.
https://doi.org/10.1093/arclin/acw090
Meares, S., Shores, E. A., Taylor, A. J., Batchelor, J., Bryant, R. A., Baguley, I. J., …
Marosszeky, J. E. (2011). The prospective course of postconcussion syndrome:
The role of mild traumatic brain injury. Neuropsychology, 25(4), 454–465.
https://doi.org/10.1037/a0022580
Mittenberg, W., Canyock, E. M., Condit, D. and Patton, C. (2001). Treatment of postconcussion syndrome following mild head injury. Journal of Clinical and
Experimental Neuropsychology, 23: 829–836.
Niemeier, J. P., Perrin, P. B., Holcomb, M. G., Nersessova, K. S., & Rolston, C. D.
(2013). Factor structure, reliability, and validity of the Frontal Systems Behavior
Scale (FrSBe) in an acute traumatic brain injury population. Rehabilitation
psychology, 58(1), 51-63.
Pagulayan, K. F., Hoffman, J. M., Temkin, N. R., Machamer, J. E., & Dikmen, S. S.
(2008). Functional Limitations and Depression After Traumatic Brain Injury:
Examination of the Temporal Relationship. Archives of Physical Medicine and
Rehabilitation, 89(10), 1887–1892. https://doi.org/10.1016/j.apmr.2008.03.019
Parcell, D. L., Ponsford, J. L., Rajaratnam, S. M., & Redman, J. R. (2006). Self-reported
changes to nighttime sleep after traumatic brain injury. Archives of Physical
Medicine and Rehabilitation, 87(2), 278–285.
https://doi.org/10.1016/j.apmr.2005.10.024
Parcell, D. L., Ponsford, J. L., Redman, J. R., & Rajaratnam, S. M. (2008). Poor sleep
quality and changes in objectively recorded sleep after traumatic brain injury: a

76

preliminary study. Archives of Physical Medicine and Rehabilitation, 89(5), 843–
850. https://doi.org/10.1016/j.apmr.2007.09.057
Pearson, N. C. S. (2009). Advanced clinical solutions for WAIS-IV and WMS-IV:
Administration and scoring manual. San Antonio: The Psychological
Corporation.
Ponsford, J., Cameron, P., Fitzgerald, M., Grant, M., & Mikocka-Walus, A. (2011).
Long-term outcomes after uncomplicated mild traumatic brain injury: a
comparison with trauma controls. Journal of Neurotrauma, 28(6), 937–946.
https://doi.org/10.1089/neu.2010.1516
Ponsford, J. L., Parcell, D. L., Sinclair, K. L., Roper, M., & Rajaratnam, S. M. W. (2013).
Changes in sleep patterns following traumatic brain injury: a controlled study.
Neurorehabilitation and Neural Repair, 27(7), 613–621.
https://doi.org/10.1177/1545968313481283
Possin, K. L., LaMarre, A. K., Wood, K., Mungas, D. M., & Kramer, J. H. (2014).
Ecological Validity and Neuroantomical Correlates of the NIH EXAMINER
Executive Composite Score. Journal of the International Neuropsychological
Society : JINS, 20(1), 20–28. https://doi.org/10.1017/S1355617713000611
Potter, S., Leigh, E., Wade, D., & Fleminger, S. (2006). The Rivermead Post Concussion
Symptoms Questionnaire: a confirmatory factor analysis. Journal of Neurology,
253(12), 1603–1614. https://doi.org/10.1007/s00415-006-0275-z
PROMIS Patient-Reported Outcomes Measurement Information System (PROMIS)
[Internet]. (2015). Available

77

at http://www.nihpromis.org/measures/availableinstruments; accessed October
26, 2018.
Prince, C., & Bruhns, M. E. (2017). Evaluation and Treatment of Mild Traumatic Brain
Injury: The Role of Neuropsychology. Brain Sciences, 7(8).
https://doi.org/10.3390/brainsci7080105
Raj, R., Skrifvars, M. B., Kivisaari, R., Hernesniemi, J., Lappalainen, J., & Siironen, J.
(2015). Acute alcohol intoxication and long-term outcome in patients with
traumatic brain injury. Journal of Neurotrauma, 32(2), 95–100.
https://doi.org/10.1089/neu.2014.3488
Rapoport, M. J., McCullagh, S., Streiner, D., & Feinstein, A. (2003). The Clinical
Significance of Major Depression Following Mild Traumatic Brain Injury.
Psychosomatics, 44(1), 31–37. https://doi.org/10.1176/appi.psy.44.1.31
Raymer, A. M., Roitsch, J., Redman, R., Michalek, A. M. P., & Johnson, R. K. (2018).
Critical appraisal of systematic reviews of executive function treatments in TBI.
Brain Injury, 32(13–14), 1601–1611.
https://doi.org/10.1080/02699052.2018.1522671

Reid-Arndt, S. A., Nehl, C., & Hinkebein, J. (2007). The Frontal Systems Behaviour
Scale (FrSBe) as a predictor of community integration following a traumatic brain
injury. Brain Injury, 21(13–14), 1361–1369.
https://doi.org/10.1080/02699050701785062
Rogers, J.M. and Read, C.A. (2007). Psychiatric comorbidity following traumatic brain
injury. Brain injury 21, 1321-1333.

78

Rosvold, H. E., Mirsky, A. F., Sarason, I., Bransome Jr., E. D., & Beck, L. H. (1956). A
continuous performance test of brain damage. Journal of Consulting Psychology,
20(5), 343–350. https://doi.org/10.1037/h0043220
Rutland-Brown, W., Langlois, J. A., Thomas, K. E., & Xi, Y. L. (2006). Incidence of
traumatic brain injury in the United States, 2003. The Journal of Head Trauma
Rehabilitation, 21(6), 544–548.
Ryan, L. M., & Warden, D. L. (2003). Post concussion syndrome. International Review
of Psychiatry, 15(4), 310–316.
https://doi.org/10.1080/09540260310001606692Schretlen, D. J., & Shapiro, A.
M. (2003). A quantitative review of the effects of traumatic brain injury on
cognitive functioning. International Review of Psychiatry (Abingdon, England),
15(4), 341–349. https://doi.org/10.1080/09540260310001606728
Schiehser, D. M., Delis, D. C., Filoteo, J. V., Delano-Wood, L., Han, S. D., Jak, A. J., …
Bondi, M. W. (2011). Are self-reported symptoms of executive dysfunction
associated with objective executive function performance following mild to
moderate traumatic brain injury? Journal of Clinical and Experimental
Neuropsychology, 33(6), 704–714.
https://doi.org/10.1080/13803395.2011.553587
Schretlen, D. J., & Shapiro, A. M. (2003). A quantitative review of the effects of
traumatic brain injury on cognitive functioning. International Review of
Psychiatry (Abingdon, England), 15(4), 341–349.
https://doi.org/10.1080/09540260310001606728

79

Segal, D. L., Coolidge, F. L., Cahill, B. S., & O’Riley, A. A. (2008). Psychometric
Properties of the Beck Depression Inventory—II (BDI-II) Among CommunityDwelling Older Adults. Behavior Modification, 32(1), 3–20.
https://doi.org/10.1177/0145445507303833
Shekleton, J. A., Parcell, D. L., Redman, J. R., Phipps-Nelson, J., Ponsford, J. L., &
Rajaratnam, S. M. W. (2010). Sleep disturbance and melatonin levels following
traumatic brain injury. Neurology, 74(21), 1732–1738.
https://doi.org/10.1212/WNL.0b013e3181e0438b
Silver, J. M., McAllister, T. W., & Arciniegas, D. B. (2009). Depression and Cognitive
Complaints Following Mild Traumatic Brain Injury. American Journal of
Psychiatry, 166(6), 653–661. https://doi.org/10.1176/appi.ajp.2009.08111676
Spreen, O., & Benton, A. L. (1977). Neurosensory Center Comprehensive Examination
for Aphasia. Victoria BC: University of Victoria, Neuropsychology Laboratory.
Stulemeijer, M., Vos, P. E., Bleijenberg, G., & van der Werf, S. P. (2007). Cognitive
complaints after mild traumatic brain injury: Things are not always what they
seem. Journal of Psychosomatic Research, 63(6), 637–645.
https://doi.org/10.1016/j.jpsychores.2007.06.023
Teasdale, G., & Jennett, B. (1974). ASSESSMENT OF COMA AND IMPAIRED
CONSCIOUSNESS: A Practical Scale. The Lancet, 304(7872), 81–84.
https://doi.org/10.1016/S0140-6736(74)91639-0
Tombaugh, T. N. (1996). Test of Memory Malingering (TOMM). New York: MultiHealth Systems, Inc.

80

Toplak, M. E., West, R. F., & Stanovich, K. E. (2013). Practitioner Review: Do
performance-based measures and ratings of executive function assess the same
construct? Journal of Child Psychology and Psychiatry, 54(2), 131–143.
https://doi.org/10.1111/jcpp.12001
Trahan, D. E., Ross, C. E., & Trahan, S. L. (2001). Relationships among
postconcussional-type symptoms, depression, and anxiety in neurologically
normal young adults and victims of mild brain injury. Archives of Clinical
Neuropsychology, 16(5), 435–445. https://doi.org/10.1016/S0887-6177(00)000512
Unsworth, N., Spillers, G. J., & Brewer, G. A. (2011). Variation in verbal fluency: A
latent variable analysis of clustering, switching, and overall
performance. Quarterly Journal of Experimental Psychology, 64, 447–466.
10.1080/17470218.2010.505292
van Velzen, J. M., van Bennekom, C. a. M., Edelaar, M. J. A., Sluiter, J. K., & FringsDresen, M. H. W. (2009). Prognostic factors of return to work after acquired brain
injury: a systematic review. Brain Injury, 23(5), 385–395.
https://doi.org/10.1080/02699050902838165
Vanderploeg, R., Curtiss, G., Luis, C., & Salazar, A. (2007). Long-term morbidities
following self-reported mild traumatic brain injury. Journal of Clinical &
Experimental Neuropsychology, 29(6), 585–598.
https://doi.org/10.1080/13803390600826587
Wechsler, D. (2001). Wechsler Test of Adult Reading: WTAR. San Antonio, TX: The
Psychological Corporation.

81

Wechsler D. (2008). Wechsler Adult Intelligence Scale–Fourth Edition. San Antonio,
TX: Pearson.
Whelan-Goodinson, R., Ponsford, J.L., Schonberger, M. and Johnston, L. (2010).
Predictors of psychiatric disorders following traumatic brain injury. The Journal
of head trauma rehabilitation 25, 320-329.
Whiteside, D. M., Kogan, J., Wardin, L., Phillips, D., Franzwa, M. G., Rice, L., …
Roper, B. (2015). Language-based embedded performance validity measures in
traumatic brain injury. Journal of Clinical and Experimental Neuropsychology,
37(2), 220–227. https://doi.org/10.1080/13803395.2014.1002758
Wickwire, E. M., Williams, S. G., Roth, T., Capaldi, V. F., Jaffe, M., Moline, M., …
Lettieri, C. J. (2016). Sleep, Sleep Disorders, and Mild Traumatic Brain Injury.
What We Know and What We Need to Know: Findings from a National Working
Group. Neurotherapeutics, 13(2), 403–417. https://doi.org/10.1007/s13311-0160429-3
Wood, R. L. (2004). Understanding the “miserable minority”: a diasthesis-stress
paradigm for post-concussional syndrome. Brain Injury, 18(11), 1135–1153.
https://doi.org/10.1080/02699050410001675906
Wood, R. L., O’Hagan, G., Williams, C., McCabe, M., & Chadwick, N. (2014). Anxiety
sensitivity and alexithymia as mediators of postconcussion syndrome following
mild traumatic brain injury. The Journal of Head Trauma Rehabilitation, 29(1),
E9–E17. https://doi.org/10.1097/HTR.0b013e31827eabba

82

Wood, R. L., & Worthington, A. (2017). Neurobehavioral Abnormalities Associated with
Executive Dysfunction after Traumatic Brain Injury. Frontiers in Behavioral
Neuroscience, 11, 195. https://doi.org/10.3389/fnbeh.2017.00195
You, S. C., Apple, A., Satris, G., Wood, K.A., Johnson, E.J., Gooblar, J., Kang, G., Sha,
S., Hess, C., Geschwind, M., Kramer, J.H., Possin, K.L. (2013). Executive
Functions in Premanifest Huntington’s Disease. Movement Disorders. doi:
10.1002/mds.25762
Zakzanis, K. K., Leach, L., & Kaplan, E. (1998). On the nature and pattern of
neurocognitive function in major depressive disorder. Neuropsychiatry,
Neuropsychology, and Behavioral Neurology, 11(3), 111–119.
Zaloshnja, E., Miller, T., Langlois, J. A., & Selassie, A. W. (2008). Prevalence of longterm disability from traumatic brain injury in the civilian population of the United
States, 2005. The Journal of Head Trauma Rehabilitation, 23(6), 394–400.
https://doi.org/10.1097/01.HTR.0000341435.52004.ac

83

Appendix A: Figures and Tables

Session 1
mTBI consented (n= 60)

Control consented (n= 33)

Excluded (n= 8)
Did not complete session 1(n=2)
No LOC (n= 2)
Sustained prior injury (n=1)
Injury > 14 days (n=3)

mTBI Sample (n=52)

Excluded (n= 1)
Sustained prior injury
(n=1)

Control Sample (n=32)

Session 2
Lost to follow-up (n=14)

Lost to follow-up (n=5)

Control Sample (n=27)

mTBI Sample (n=38)

Figure 1. Consort diagram of study participants with attrition.

84

Table 1.
Demographics of individuals with a mTBI and Control participants
Variables
mTBI
Control
(n = 52)
(n=32)
n (%)
n (%)
Sex
Male
33 (63.5) 16 (50.0)
Female
19 (36.5) 16 (15.0)
Age
(years)a

29.9(10.2) 29.6 (10.6)

Total

Significance
Test

n (%)
p = .224
49 (57.0)
35 (40.7)
29.2 (10.3)

p = .787
p = .111

Race
Black
Asian
White
Native American
Other

1 (1.9)
0 (0)
30 (57.7)
8 (15.4)
13(25.0)

2 (6.3)
1 (3.1)
24 (75.0)
2 (6.3)
3 (9.4)

3 (3.5)
1 (1.2)
54 (62.8)
10 (11.6)
16 (18.6)
p = .161

Ethnicity
Non-Hispanic White
Hispanic or Latino

26 (50.0)
26 (50.0)

21 (65.6)
11 (34.4)

47 (54.7)
37 (43.0)

Less than High School
High School or GED
More than High
School

7 (13.5)
10 (19.2)
35 (67.4)

1 (13.1)
4 (12.5)
27 (84.4)

8 (9.5)
14 (16.3)
62 (72.1)

Education

p =.204

Marital
Status

p = .218
Never Married
Married
Domestic Partnership
Divorced
Separated
Widowed

39 (75.0)
4 (7.7)
4 (7.7)
2 (3.8)
1 (1.9)
2 (3.8)

aMean(SD)

Note: Significance testing 2 or t-test
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18 (56.3)
8 (25.0)
4 (12.5)
1 (3.1)
1 (3.1)
0 (0)

57 (66.3)
12 (14.0)
8 (9.3)
3 (3.5)
2 (2.3)
2 (2.3)

Table 2.
Employment Variables
Variables

mTBI
(n = 52)
n (%)

Control
(n = 32)
n (%)

Total
n (%)

31 (59.6)
3 (5.8)

20 (62.5)
1 (3.1)

51 (59.3)
4 (4.7)

6 (11.5)
1 (1.9)
3 (5.8)
0 (0)
4 (7.7)
4 (7.7)

4 (12.5)
0 (0)
1 (3.1)
1 (3.1)
3 (9.4)
2 (6.2)

10 (11.6)
1 (1.2)
4 (4.7)
1 (1.2)
7 (8.1)
26 (7.0)

14 (26.9)
2 (3.8)
7 (13.5)
6 (11.5)
8 (15.4)
0 (0)
2 (3.8)
1 (1.9)
6 (11.5)
5 (9.6)
1 (1.9)

3 (9.4)
0 (0)
8 (25.0)
5 (15.6)
3 (9.4)
3 (9.4)
0 (0)
0 (0)
6 (18.8)
3 (9.4)
1 (3.1)

17 (19.8)
2 (2.3)
15 (17.4)
11 (12.8)
11 (12.8)
3 (3.5)
2 (2.3)
1 (1.2)
12 (14.0)
8 (9.3)
2 (2.3)

Employment
Status
Working now
Only temporarily laid off, sick leave,
maternity leave
Looking for work, unemployed
Retired
Disabled, permanently or temporarily
Keeping House
Student
Other
Job
Classification
None
Official/Manager
Professional
Technical
Sales Worker
Craft Worker
Operative
Administrative Support
Laborer/Helper
Service Worker
Unknown
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Figure 2. mTBI reported mechanism of injury
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Table 3.
Pearson Correlations between BDI-II, pain, and sleep measures
Pain
Pain
BDI-IIa
Interferencea
Intensitya
BDI-II
Pain Interference
.589*
Pain Intensity
.457*
.879*
Sleep Disturbanceb
.553*
.552*
.553*
an = 83, bn = 84
*. Correlation is significant at the 0.01 level (2-tailed).
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Figure 3. Number of individuals in each group who reported experiencing minimal, mild,
moderate and severe depression symptoms on the BDI-II at the sub-acute time point.
= mTBI,
____= Control.

89

Table 4.
Pearson Correlations between symptom, sleep, pain, and executive measures in the mTBI group
at the sub-acute time point
NSI
NSI
NSI
Somatica Cognitivea Emotiona
NSI Somatic
NSI Cognitive
NSI Emotion
FrSBe
Sleep
Disturbance
Pain
Interference
Pain Intensity
Executive
Compositec

FrSBea

Sleep
Pain
Pain
Disturbanceb Interferenceb Intensityb

.82**
.80**
.46**

.85**
.55**

.57**

.34*

.37**

.54**

.32*

.57**

.54**

.68**

.57**

.44**

.52**

.35*

.52**

.36**

.41**

.79**

.09

.15

.07

.13

-.20

-.05

Note: NSI Somatic = Neurobehavioral Symptom Inventory Somatic sub-scale; NSI Cognitive =
Neurobehavioral Symptom Inventory Cognitive sub-scale; NSI Emotion = Neurobehavioral
Symptom Inventory Emotion sub-scale; FrSBe = Frontal Systems Behavior Scale.
an = 52, bn = 51, cn=47
**. Correlation is significant at the 0.01 level (2-tailed).
*. Correlation is significant at the 0.05 level (2-tailed).

90

-.15

Table 5.
Mechanism of Injury by Gender
Female
N
18
Assault
2
Vehicle
8
Fall
6
Sports Related
2

Male
34
5
19
3
7

Total
52
7
27
9
8
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Chi-Square
.164

Table 6.
Assessment variables reported mean, standard deviation and t-test significance between both
groups at the sub-acute time point
mTBI
Control
n
Mean (SD)
n
Mean (SD)
t-Test
TOPF Total Std. Score
51
94.5 (14.3)
32
105 (12.7)
p = .001
BDI-II
52
13.1 (11.0)
32
5.78 (6.9)
p = .001
Symptom Composite PC
52
105.27 (15.7)
31
91.16 (8.27)
p < .001
NSI Somatic
52
12.1 (10.8)
31
2.06 (2.8)
p < .001
NSI Cognitive
52
5.13 (4.85)
31
1.29 (2.1)
p < .001
NSI Emotion
52
8.48 (6.3)
31
3.35 (4.3)
p < .001
NSI Total
52
25.8 (20.6)
31
6.71 (8.7)
p < .001
FrSBe
52
60.8 (17.1)
31
52.1 (15.5)
p = .021
Executive Composite
47
109.18 (7.89)
29
114.33 (7.14)
p = .005
Fluency Factor
47
106.15 (9.55)
29
113.19 (8.79)
p = .002
Cognitive Control Factor
47
112.37(9.68)
29
115.02 (6.73)
p = .199
Working Memory Factor
47
105.03 (.9.42)
29
107.68 (.10.91)
p = .266
Note: TOPF Total Std. Score = Test of Premorbid Functioning Total Standard Score; BDI-II =
Beck Depression Inventory II; NSI Somatic = Neurobehavioral Symptom Inventory Somatic subscale; NSI Cognitive = Neurobehavioral Symptom Inventory Cognitive sub-scale; NSI Emotion
= Neurobehavioral Symptom Inventory Emotion sub-scale; NSI Total = Neurobehavioral
Symptom Inventory Total Score; FrSBe = Frontal Systems Behavior Scale; Executive Composite
= Executive Composite from the NIH-EXAMINER, Fluency Factor = Fluency Factor of the NIHEXAMINER, Cognitive Control Factor = Cognitive Control Factor of the NIH-EXAMINER;
Working Memory Factor = Working Memory Factor of the NIH-EXAMINER.

92

Table 7.
Symptom Measure Correlations
NSI
NSI
NSI
Somatica
Cognitivea
Emotiona
NSI Totala
NSI Somatic
NSI Cognitive
.851*
NSI Emotion
.818*
.863*
NSI Total
.964*
.935*
.931*
FrsBe Totala
.514*
.584*
.610*
.589*
an = 83.
*. Correlation is significant at the 0.01 level (2-tailed).
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Table 8.
Pearson Correlations of Executive Functioning Variables
Executive
Cognitive Control
Compositea
Fluency Factora
Factora
Executive Composite
Fluency Factor
.799*
Cognitive Control Factor
.622*
.192
Working Memory Factora
.657*
.343*
.314*
an = 76.
*. Correlation is significant at the 0.01 level (2-tailed).
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Figure 4. Mean BDI-II scores by group at the sub-acute and chronic time points.
= Control. Error bars: +/- 2 SE.
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Figure 5. BDI-II scores at the sub-acute and chronic time points for mTBI and control
participants
= mTBI
= healthy control.
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Figure 6. TOPF high and low scores by median split organized by group by BDI-II scores at the
sub-acute time point
= high TOPF score,
= low TOPF score.
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Figure 7. Histogram of TOPF Total Standard Score by frequency for each group at the chronic
time point.
= mTBI,
= Control.
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Figure 8. Mean Symptom Composite PC scores by group at the sub-acute and chronic time
points.
= mTBI,
= Control. Error bars: +/- 2 SE.
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Figure 9. Mean Executive Composite scores by group at the sub-acute and chronic time points.
___= mTBI,
= Control. Error bars: +/- 2 SE.
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Figure 10. Mean Fluency Factor scores by group at the sub-acute and chronic time points.
mTBI,
_= Control. Error bars: +/- 2 SE.
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_=

Figure 11. Mean Cognitive Control Factor scores by group at the sub-acute and chronic time
points. _= mTBI, ___= Control. Error bars: +/- 2 SE
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Figure 12. Mean Working Memory Factor scores by group at the sub-acute and chronic time
points. _= mTBI, ___= Control. Error bars: +/- 2 SE.
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